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Abdullah	Hamad	Alzeer	IDENTIFY	OPIOID	USE	PROBLEM	The	 aim	of	 this	 research	 is	 to	 design	 a	 new	method	 to	 identify	 the	 opioid	 use	problems	 (OUP)	 among	 long-term	 opioid	 therapy	 patients	 in	 Indiana	 University	Health	using	text	mining	and	machine	learning	approaches.	First,	a	systematic	review	was	 conducted	 to	 investigate	 the	 current	 variables,	methods,	 and	 opioid	 problem	definitions	used	in	the	literature.	We	identified	75	distinct	variables	in	9	models	that	majorly	used	ICD	codes	to	identify	the	opioid	problem	(OUP).	The	review	concluded	that	using	ICD	codes	alone	may	not	be	enough	to	determine	the	real	size	of	the	opioid	problem	and	more	effort	is	needed	to	adopt	other	methods	to	understand	the	issue.	Next,	we	developed	a	text	mining	approach	to	identify	OUP	and	compared	the	results	with	 the	 current	 conventional	 method	 of	 identifying	 OUP	 using	 ICD-9	 codes.	Following	 the	 institutional	 review	 board	 and	 an	 approval	 from	 the	 Regenstrief	Institute,	 structured	 and	unstructured	data	 of	 14,298	 IUH	patients	were	 collected	from	the	Indiana	Network	for	Patient	Care.	Our	text	mining	approach	identified	127	opioid	cases	compared	to	45	cases	identified	by	ICD	codes.	We	concluded	that	the	text	mining	 approach	may	 be	 used	 successfully	 to	 identify	 OUP	 from	 patients	 clinical	notes.	 Moreover,	 we	 developed	 a	 machine	 learning	 approach	 to	 identify	 OUP	 by	analyzing	patients’	clinical	notes.	Our	model	was	able	to	classify	positive	OUP	from	clinical	 notes	 with	 a	 sensitivity	 of	 88%	 on	 unseen	 data.	 We	 concluded	 that	 the	machine	 learning	 approach	 may	 be	 used	 successfully	 to	 identify	 the	 opioid	 use	problem	from	patients’	clinical	notes.	 Josette	Jones,	Ph.D.,	Chair	
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1. INTRODUCTION	
 Synopsis	Medical	and	non-medical	use	of	opioids	has	increased	in	the	United	States	(U.S.)	for	the	last	decade	for	patients	with	chronic,	non-cancer	pain	[1–4].	Prescriptions	of	opioid	analgesics,	such	as	morphine,	fentanyl,	oxycodone,	and	hydromorphone,	have	increased	 dramatically	 as	 shown	 in	 multiple	 studies	 [1,5–7].	 According	 to	 The	National	Health	and	Nutrition	Examination	Survey,	25%	of	Americans	20	years	and	older	 have	 experienced	pain	 that	 has	 lasted	 over	 24	hours	 in	 the	 past	month	 [8].	Despite	the	clinical	 importance	of	opioids	in	the	management	of	pain,	opioids	may	have	significant	and	adverse	societal	effects.	Notably,	these	can	include	the	epidemic	of	opioid	abuse	and	opioid	use	disorder	with	related	socio-economic	and	criminal	impacts,	 as	 well	 as	 deaths	 attributed	 to	 overdose	 [9].	 Achieving	 effective	 pain	management,	 along	 with	 maintaining	 functionality	 and	 healthy	 participation	 in	society,	 cannot	 be	 accomplished	 with	 the	 high	 occurrence	 of	 opioid	 addiction.	Therefore,	understanding	the	risks	and	benefits	of	prescribing	opioids	is	important	to	reduce	the	related	opioid	abuse	epidemic	[10–13].	The	financial	burden	associated	with	the	opioid	use	problems	(OUP)	is	significant.	The	cost	of	treatment	for	patients	with	OUP	 represents	 a	 large	 portion	 of	 the	 cost	 of	 rehabilitation	programs,	 social	consequences,	 public	 safety,	 legal	 proceedings,	 and	 so	 on	 [14,15].	 The	 total	 US	societal	costs	of	prescription	opioid	OUP	were	estimated	to	be	$11.8	billion	in	2001,	increasing	 to	 $55.7	 billion	 in	 2009	 [16].	 The	 societal	 effect	 of	 prescribed	 opioids	extends	beyond	financial	burden	to	health	matters,	according	to	the	National	Institute	
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of	Drug	Abuse;	prescribed	opioids	were	responsible	for	over	16,000	deaths	in	2014,	alone.	This	number	increased	from	nearly	6,000	deaths	in	2001	[17].	
 Overview	of	the	Opioid	Use	Problems	(OUP)	
 Opioid	Overdose	Death	In	2015,	according	to	the	Centers	for	Disease	Control	and	Prevention	(CDC),	drug	overdose	was	 the	 leading	 cause	of	 accidental	 death	 in	 the	U.S.,	with	55,403	death	incidents	 [18].	 Opioid	 addiction	 alone	 is	 responsible	 for	 20,101	 (36%)	 of	 these	overdose	death	incidents	[19].	The	CDC	has	concluded	that	91	Americans	die	every	day	 using	 prescription	 opioids	 and	 heroin,	 together	 [19].	 To	 understand	 the	relationship	between	heroin	and	OUP,	according	to	Jones	(2013),	80%	(four	out	five)	of	new	heroin	users	have	started	with	prescribed	painkillers,	such	as	opioids	[20].	Figure	1.1	shows	the	pattern	of	drug	overdose	deaths	 involving	opioids	by	type	of	opioid	in	U.S	from	2000	to	2014.	[21]	Unfortunately,	a	large	part	of	the	opioids	that	are	 available	 illicitly	 are	 originate	 from	 prescribed	 opioids.	 In	 2012,	 259	 million	prescriptions	were	prescribed	for	opioids	[22].	This	quantity	is	sufficient	to	supply	every	American	adult	with	his	or	her	own	bottle	[18].	
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	Figure	1.1	Increases	in	drug	and	opioid	overdose	deaths	–	U.S.,	2000–2014	
 Opioid	Use	Problems	and	Women	Drug	abuse	affects	men	and	women	in	different	ways;	despite	men	being	more	likely	to	die	of	painkiller	overdose,	between	1999	and	2010,	the	overdose	rate	among	women	 has	 increased	 by	 more	 than	 400%	 compared	 to	 men,	 whose	 rate	 has	increased	256%	 [23].	Moreover,	women	may	become	dependent	on	opioids	more	quickly	 than	 men	 and	 engage	 in	 doctor	 shopping	 more	 than	 men,	 as	 well	 [23].	Another	important	factor	unique	to	women	is	pregnancy;	addicted	pregnant	women	can	put	infants	health	at	risk	from	neonatal	abstinence	syndrome	[23].	
 Opioid	Use	Problems	in	Adolescents	and	Young	Adults	Despite	 the	 fact	 that	 the	 focus	 of	 this	 proposal	 is	 adult	 chronic	 patients,	 it	 is	important	to	understand	that	opioid	consumption	also	affects	adolescents.	In	2015,	an	 estimated	276,000	 adolescents	 between	 ages	12	 and	17	misused	opioids,	with	122,000	 having	 an	 addiction	 to	 prescription	 pain	 relievers	 [18].	 Moreover,	 the	number	nearly	 tripled	 to	829,0000	young	adults	 from	age	18	 to	25	 in	one	month	(Figure	1.2)	[24].	According	to	the	National	Institute	of	Drug	Abuse,	most	adolescents	
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who	 misuse	 opioids	 obtained	 their	 drugs	 for	 free	 from	 a	 friend	 or	 relative	 [25].	Adolescents	can	obtain	their	own	prescriptions,	as	well.	In	fact,	from	1999	to	2010,	the	number	of	opioid	prescriptions	among	adolescent	has	nearly	doubled	[26].	
 The	Opioid	Use	Problems	in	Indiana	The	State	of	Indiana	has	its	share	of	opioid	epidemics;	a	recent	report	from	the	Richard	 M.	 Fairbanks	 School	 of	 Public	 Health	 (September	 2016)	 has	 reported	shocking	facts	regarding	OUP.	According	to	the	source,	between	1999	to	2014,	the	number	of	 opioid	overdoses	has	 increased	by	600%	 [27]	 (Figure	1.3).	 In	 fact,	 the	leading	cause	of	injury	deaths	in	Indiana	is	poisoning,	and	most	of	these	deaths	are	drug	overdoses	 (9	out	of	10)	 [27].	Drug	overdoses	overtook	 the	number	of	motor	vehicle	deaths	in	Indiana	[27].	Most	of	these	drug	overdoses	were	in	the	group	aged	30-39,	followed	by	the	group	aged	50-59	[27].	With	regard	to	gender,	more	men	die	from	drug	overdoses;	however,	the	gap	has	shrunk	over	the	years	[27].	Heroin	deaths	have	also	increased	since	2007	(Figure	1.3);	most	were	male,	non-Hispanic	whites,	and	people	between	the	ages	of	30-39	had	the	highest	death	rate	from	heroin	[27].	More	interesting	facts	can	be	found	in	the	report	[27].	
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	Figure	1.2	Key	substance	use	and	mental	health	indicators	in	the	U.S.:	Results	from	the	2015	national	survey	on	drug	use	and	health.	Source:	SAMHSA,	2016	
	Figure	1.3	Report	on	the	toll	of	opioid	use	in	Indiana	and	Marion	county.		Source:	Duwve,	J.	et	al.,	2016	
 Problem	Statement	
 Physicians’	Role	in	Identifying	Opioid	Use	Problems	Pain-specialist	 physicians	 would	 be	 best	 suited	 to	 assess	 OUP	 overall	 and	prescribe	proper	pain-management	action.	However,	due	to	the	 limited	number	of	painspecialist	physicians	and	their	accessibility	to	the	general	public,	primary	care	physicians	most	often	provide	the	majority	of	pain	care	in	the	health	system	[28].	In	a	study	published	 in	2016	 investigating	 the	prescribing	of	schedule	 II	medications	among	types	of	physicians,	it	was	found	that	family	practitioners	prescribe	over	15.3	million	prescriptions;	whereas	 internal	medicine	practitioners	prescribe	over	12.7	
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million	 prescriptions	 [29]	 (Figure	 1.4).	 This	 prescribing	may	 be	 due	 to	 improper	specialized	 training	 and	 educational/technical	 support,	 among	 other	 factors.	However,	 despite	 various	 root	 casues	 of	 the	 issue,	 primary	 care	 physicians	 have	reported	 frustration	 when	 providing	 care	 for	 chronic-pain	 patients	 [30–34].	 In	 a	qualitative	 study	 published	 in	 2015,	 some	 physicians	 admitted	 they	 have	 been	manipulated	many	times	and	have	prescribed	opioids	for	patients	who	exaggerated	their	 pain	 or	 for	 other	 patients	who	 had	 tested	 positive	 several	 times	 for	 heroin.	However,	physicians	sometimes	make	the	mistake	of	not	prescribing	medication	to	patients	 who	 actually	 are	 in	 need,	 according	 to	 the	 same	 qualitative	 study	 [28].	Therefore,	relying	on	clinical	 judgment	alone	might	misguide	physicians	to	choose	the	correct	course	of	action	to	manage	chronic-pain	patients.	
	Figure	1.4	Distribution	of	opioids	by	different	types	of	Medicare	prescribers	
 Self-Report	Opioid	Risk-Assessment	Tools	Multiple	self-report	risk-assessment	tools	have	been	designed	and	validated	to	some	extent	 in	 recent	 years	 [35–38].	 Existing	 opioid	 risk-assessment	 tools	 vary	 in	 the	source	of	identifying	predicting	variables	(knowledge	base	vs.	database	prediction)	and	 the	 purpose	 of	 use	 (initiation	 of	 treatment	 vs.	 monitoring	 of	 care).	 For	 the	purpose	 of	 this	 dissertation,	 we	 categorize	 opioid	 risk-assessment	 tools	 into	 two	categories:	 self-report	 base	 vs.	 database	 tools.	 We	 define	 self-report-based	 risk-assessment	tools	as	risk-assessment	tools	that	predict	the	risk	of	current	or	future	opioid	use	problems	based	on	predictive	variables	extracted	from	data	self-reported	
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by	 the	 patient	 or	 physician.	 We	 define	 database	 risk-assessment	 tools	 as	 risk-assessment	tools	that	predict	the	risk	of	current	or	future	opioid	use	problems	based	on	 objective	 data	 extracted	 from	 a	 database,	 such	 as	 electronic	 health	 records	 or	claims	administrative	data	(Figure	1.5).	
	Figure	1.5	Overview	of	sources	and	purpose	of	opioid	risk	assessment	tools	Common	 examples	 of	 self-report	 tools	 are	 SOAPP,	 ORT,	 and	 COMM.	 However,	having	the	majority	of	risk-assessment	tools	solely	rely	on	patient	completion	might	limit	their	ability	to	predict	aberrant	drug	behavior	due	to	reporting	bias	[39]	or	lack	of	patient	comprehension	[40].	Jones	et	al.,	(2012)	conducted	a	study	that	is	unique	in	 that	 it	 compared	 original	 ORT	 (patient	 self-reported)	 vs.	 ORT	 (psychologist	completed	after	conducting	an	interview)	among	51	patients;	only	30	(59%)	patients	matched	in	the	same	risk	category.	Among	all	variables,	age	had	the	highest	rate	of	
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agreement,	 with	 only	 an	 86%	 level	 of	 agreement	 [40].	 Overall	 predictive	 ability	varied,	as	well	between	the	two	ORTs;	predictive	ability	for	psychologist-completed	ORT	was	 better	 (43%	 vs.	 70%	missing	 rate)	 [40].	 These	 results	 indicate	 that	 the	process	of	administration	of	the	opioid	risk-assessment	tool	itself	could	play	a	role	in	determining	the	overall	predictive	ability	of	the	tool;	perhaps	patient	education	and	leveraging	physicians	with	more	accurate	and	robust	data	from	health	care	databases	might	 help	 to	minimize	 the	 issue.	 A	 second	 issue	 of	 using	 self-report	methods	 to	assess	opioid	risk	 is	the	process	of	documentation	itself.	This	challenge	becomes	a	monthly	burden	on	the	clinical	staff,	nurses,	and	physicians	who	are	conducting	the	documentation	 process.	 Understanding	 the	 challenge	 of	 documentation,	 Butler	conducted	 a	 study	 to	 examine	 the	 effect	 of	 computerizing	 current	 methods	 of	administrating	SOAPP	and	COMM	(self-report	type)	on	the	rate	of	documentation	of	these	tools.	The	author	designed	the	web-based	tool	and	implemented	it	in	two	pain	centers	for	a	period	of	10	months.	Both	sites	used	paper-based	versions	of	SOAPP-R	and	COMM.	The	results	showed	a	significant	increase	in	the	documentation	of	opioid	risk	assessment	for	both	initial	and	follow-up	visits	(SOAPP	30.3%	vs.	76.9/5,	COMM	4.5%	 vs.	 43.6%)	 (p	 <	 .001).	 Such	 a	 study	 highlights	 the	 significant	 issue	 with	documentation	in	current	self-report	methods	[41].	A	 third	 issue	 with	 self-reported	methods	 is	 the	 variation	 of	 prediction	 ability	(reliability)	in	the	literature;	SOAPP	is	one	of	the	most	validated	tools	we	found	in	the	literature.	Based	on	this	review,	there	is	a	large	variation	in	the	sensitivity	of	the	tool	to	predict	OUP.	The	sensitivity	and	specificity	of	SOAPP	for	one	source	was	0.91	and	0.69	[42]	and	0.392	and	0.693	in	another	[43],	respectively.	The	same	argument	can	
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be	applied	to	ORT,	in	which	one	study	reported	a	sensitivity	of	0.45	[44]	and	another	reported	a	sensitivity	of	0.195	[43].	One	way	to	explain	this	variation	could	be	the	difference	in	defining	the	outcome	in	the	validation	studies	reviewed.	
 The	Statement	of	Purpose	Due	to	the	limited	number	of	pain	specialists,	primary	care	physicians	prescribe	a	significant	 portion	 of	 opioids.	 Primary	 care	 physicians	 have	 reported	 frustration	when	providing	care	for	chronic-pain	patients.	Our	objective	is	to	inform	the	clinical	and	research	community	about	 factors	 contributing	 to	 the	 incidence	of	opioid	use	problems.	Given	 the	 lack	 of	 census	 on	 structured	 variables’	 rule	 to	 identify	 opioid	 use	problems	in	the	literature,	we	seek	to	identify	studied	variables	in	the	literature	and	classify	their	rules	in	terms	of	protection	or	being	risk	factors	to	opioid	use	problems.	Additionally,	while	80%	of	health	data	are	stored	as	unstructured	data,	the	current	tools	 to	 identify	 opioid	 use	 problems	 majorly	 rely	 on	 patient-reported	 data	 or	structured	 data	 in	 the	 electronic	 medical	 records.	 Thus,	 we	 seek	 to	 utilize	unstructured	 data	 to	 develop	 a	 predictive	 model	 for	 those	 who	 are	 at	 risk	 of	developing	opioid	use	problems	using	text	mining	and	machine	learning	approaches.	
 Dissertation	Aims	1. Conduct	a	systematic	review	of	previous	opioid	use	problems	(OUP)	predictive	models	to:	(a) Identify	variables	available	in	the	literature	to	predict	OUP.	(b) Explore	and	compare	methods	(population,	database,	and	analysis)	used	to	develop	statistical	models	that	predict	OUP.	
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(c) Understand	how	outcomes	were	defined	in	each	statistical	model	OUP.	2. Identify	and	compare	patients	with	opioid	use	problems	(OUP)	using	the	text	mining	vs.	ICD	codes.	(a) Identify	positive	opioid	use	problems	patients	using	text-mining	approach.	(b) Identify	positive	opioid	use	problems	patients	using	the	ICD-9	codes.	(c) Compare	the	results	and	population	characteristics.	3. Develop	a	predictive	model	for	those	who	are	at	risk	of	developing	OUP	using	a	machine	learning	approach.	(a) Identify	a	gold	standard	subset	of	medical	reports.	(b) Identify	best	configurations	to	build	machine	learning	model.	(c) Build	a	model	that	predicts	opioid	use	problems	based	on	patients’	clinical	notes.	
 Definition	of	Terms	To	understand	the	complexity	of	the	problem,	there	are	several	terms	related	to	opioid	 use	 that	 need	 to	 be	 defined:	 opioid	 addiction,	 opioid	 abuse,	 aberrant	 drug	taking	behavior	(ADTB),	and	opioid	use	problems	(OUP).	According	to	R.	West	and	J.	Brown	 in	 their	 book,	Theory	of	Addiction,	 2012,	 addiction	 is	 defined	 as	 a	 chronic	condition	in	which	there	is	a	repeated	powerful	motivation	to	engage	in	a	rewarding	behavior,	 acquired	 as	 a	 result	 of	 engaging	 in	 that	 behavior,	 that	 has	 significant	potential	for	unintended	harm.	It	is	not	all-or-none,	but	a	matter	of	degree.	[45].	The	 second	 term	 is	 opioid	 abuse.	 In	 general,	 substance	 abuse	 is	 an	 initial	 step	towards	addiction	and	dependence.	The	World	Health	Organization	(WHO)	defines	substance	 abuse	 as	 the	 harmful	 or	 hazardous	 use	 of	 psychoactive	 substances,	
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including	alcohol	and	illicit	drugs.	[46]	Some	attributes	that	characterize	substance	abuse	are:	failure	to	fulfill	social	or	work	obligations,	continued	use	of	a	substance	in	hazardous	situations,	legal	problems	related	to	substance	abuse,	and	persistent	use	despite	continued	and	recurrent	problems	[47].	Substance	abuse	and	dependence	are	now	combined	into	substance	use	disorder	(SUD),	which	is	measured	on	a	continuum	from	mild	to	severe	according	to	Diagnostic	and	Statistical	Manual	of	Mental	Disorders,	Fifth	Edition	(DSM	5).	As	this	area	of	study	has	 developed,	 so	 have	 the	 defining	 criteria	 related	 to	 substance	 use	 disorders.	Categorization	within	the	spectrum	of	SUD	requires	at	least	two	to	three	symptoms	-instead	of	one-	from	a	list	of	11	criteria	for	mild	stage	[48].	While	these	criteria	are	available	in	detail	at	www.DSM5.org	[48],	it	is	important	to	note	that	the	tolerance	criterion	 and	 withdrawal	 symptoms	 for	 opioid	 use	 disorder	 “does	 not	 apply	 for	diminished	effect	when	used	appropriately	under	medical	supervision”	[49].	Aberrant	drug	taking	behaviors	(ADTB)	are	defined	as	“behaviors	that	are	more	likely	to	be	associated	with	medication	abuse	and	/or	addiction”	[50].	Examples	of	these	behaviors	are:	1)	selling	prescription	drugs,	2)	concurrently	abusing	alcohol	or	other	 illicit	drugs,	and	3)	 losing	prescribed	medication	on	multiple	occasions	 [51–	53].	It	is	worth	mentioning	that	some	behaviors	could	look	like	ADTB,	but	in	fact,	they	might	indicate	undertreatment	or	may	be	more	part	of	stabilizing	the	pain	condition	[54].	 Examples	 of	 these	 behaviors	 are:	 1)	 asking	 for,	 or	 even	 demanding,	 more	medication,	2)	asking	for	specific	medications,	3)	use	of	the	pain	medication	to	treat	other	 symptoms	 [54].	 Despite	 the	 evolving	 nature	 of	 these	 terminologies,	 it	 is	
	12	
important	 for	 researchers	 and	 treating	 prescribers	 to	 understand	 that	 there	 is	 a	spectrum	of	addiction.	For	 this	 study,	 we	 define	 the	 final	 term,	 opioid	 use	 problems	 (OUP)	 as	 the	presence	of	opioid	aberrant	behaviors,	opioid	misuse,	opioid	abuse	and	opioid	use	disorder	in	the	patient	electronic	health	record	(clinical	notes	and/or	ICD	codes).	A	list	of	ICD	codes	and	a	list	of	specific	criteria	of	aberrant	behaviors	(for	the	clinical	note)	are	provided	in	the	method	section	(Appendix	A.3	and	Table	3.1).	 	
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2. CONDUCT	A	SYSTEMATIC	REVIEW	OF	PREVIOUS	OPIOID	USE	PROBLEMS	
(OUP)	
 Objective	Several	 opioid	 risk	 assessment	 tools	 are	 available	 to	 prescribers	 to	 evaluate	opioid	analgesic	abuse	among	patients	with	chronic	pain.	The	aim	of	this	systematic	review	is	to	answer	the	following	questions:	1)	What	variables	have	been	examined	in	 the	 literature	 to	 predict	 opioid	 abuse?	 2)	 What	 are	 the	 methods	 (population,	database,	and	analysis)	used	to	develop	the	statistical	models	to	create	the	tool?	3)	How	were	the	outcomes	defined	in	each	statistical	model?	The	results	of	this	chapter	was	published	in	a	paper	titled:	“Review	of	factors,	methods,	and	outcome	definition	in	designing	opioid	abuse	predictive	models.	Pain	Medicine,	19(5),	997-1009.”	
 Method	A	pharmacist	with	research	experience	used	EBSCO	and	PubMed	to	conduct	a	two-stage	systematic	search	to	identify	several	articles	that	are	directly	related	to	the	topic	of	risk	assessment.	First,	the	pharmacist	identified	8	articles	that	were	deemed	to	be	directly	related	to	the	topic.	The	second	step	was	to	conduct	a	systematic	search	using	OVID	to	generate	a	list	of	articles	that	should	have	all	8	articles	of	relevance.	The	idea	behind	choosing	this	method	is	ensuring	all	common	articles	of	relevance	are	 included	 in	one	 combined	 search,	which	perhaps	will	 yield	more	new	articles	related	to	the	topic,	as	well.	Finally,	authors	of	some	of	the	articles	found	were	also	contacted	mainly	through	email	or	over	the	phone	to	require	further	data	about	their	work	or	to	identify	other	related	work.	The	search	was	limited	to	articles	written	in	English	featuring	human	adult	subjects	published	from	January	1990	to	April	2016.	
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This	search	generated	1409	articles.	Duplicate	articles	were	automatically	checked	using	Endnote	X7	and	then	manually	reviewed.	Out	of	1409	articles,	43	articles	were	duplicates	 and	 excluded.	 The	 pharmacist	 reviewed	 the	 titles	 and	 abstracts	 of	 the	remaining	1366	articles	(Figure	2.1).	The	inclusion/exclusion	criteria	were	the	following:	1. The	included	articles	were	original	studies,	not	narrative	reviews.	2. The	included	studies	focused	on	risk	for	aberrant	drug-related	behaviors.	3. Studies	included	quantitative	data	specific	to	prediction	capability	(odds	ratio,	p-value,	or	confidence	interval).	4. Studies	that	focused	on	self-administered	tools	were	excluded.	5. Only	studies	that	used	algorithms	to	predict	opioid	abuse	from	data	extracted	from	electronic	health	records	or	administrative	claims	were	included.	After	 applying	 the	 inclusion/exclusion	 criteria,	 27	 full-text	 articles	 were	downloaded.	Of	these	articles,	20	articles	were	excluded,	because	of	their	focus	on	selfreport	 tools	 (Figure	2.1).	Variables	of	 interest	were	extracted	and	 listed	on	an	Excel	 spreadsheet	 for	 all	 7	 articles	 included.	 To	 check	 face	 validity	 and	 data	consistency,	a	primary	care	physician	reviewed	extracted	data,	 including	variables	from	articles,	categorization	of	variables	from	articles,	method	(population,	database,	analysis)	used,	and	outcome	definition	(opioid	abuse).	
 Results	During	our	systematic	review,	we	identified	seven	articles	[55–61]	(nine	models)	to	assess	opioid	risk	from	databases	(claims	data	or	EHR),	which	will	be	the	subject	of	this	review.	All	nine	models	provided	definitions	of	the	outcome	of	opioid	abuse	as	
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well	 as	 variables	 used	 to	predict	 the	 outcome.	The	 following	 sections	will	 discuss	important	findings	with	regard	to	variables,	methods,	and	outcome	definitions	for	the	coinciding	models.	
	Figure	2.1	Articles	extraction	process	
 Variables	Among	the	retrieved	studies,	9	models	and	75	distinct	variables	were	identified.	The	 variables	 were	 grouped	 into	 7	 main	 categories;	 demographics	 (6	 variables),	medications	(33	variables),	care	utilization	visits	(3	variables),	behavior	(7	variables),	mental	 status	 (1	 variable),	 pain	 and	medical	 comorbidities	 (15	variables),	 pain	 (4	variables),	and	family	history	of	substance	abuse	and	comorbidities	(6	variables).	The	 identified	 models	 most	 commonly	 included	 demographic	 variables;	 age	 and	gender	were	mentioned	in	all	9	models.	History	of	alcohol	abuse,	smoking	status	and	
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mental	diagnosis	were	mentioned	in	5	models.	Table	2.1	lists	all	variables	mentioned	in	3	models	or	more	out	of	9	models.	
 Method:	Studied	Population,	Database	Used	and,	Analysis	As	mentioned	previously,	 this	 review	 found	3	 studies	 that	used	administrative	claims	data	and	4	studies	that	used	electronic	health	record	data.	In	1	of	the	4	articles,	a	disease	management	program	database	was	used	in	addition	to	health	record	data.	The	number	of	patients	included	in	the	studies	varied	greatly	from	196	to	1,552,489.	Studies	that	used	ICD-9	codes	as	a	primary	source	of	defining	their	cohort	included	larger	sample	sizes	compared	to	studies	that	did	not	use	ICD	codes.	This	sample	size	variation	 is	 related	 to	 study	 design	 and	 coincides	 with	 the	 nature	 of	 data	 used.	Administrative	claims	data	is	likely	national	data,	while	EMR	data	is	representative	of	a	 single	 site	 or	 single	 health	 care	 system.	 The	 inclusion	 criteria	 for	 a	 study’s	population	 were	 similar,	 age	 from	 12	 (or	 18)	 to	 64,	 at	 least	 one	 claim	 for	 a	prescription	opioid	in	the	past	12	months,	or	a	history	of	receiving	opioids	for	30	to	90	consecutive	days.	Exclusion	criteria	were	cancer	pain	and	heroin	poisoning.	Table	2.2	details	the	methods	for	each	article.	Finally,	in	terms	of	analysis	used,	all	studies	used	logistic	regression	as	their	primary	multivariate	analysis	method.	Using	logistic	regression	for	this	purpose	is	consistent	with	the	common	practice	in	the	field,	which	recommends	using	logistic	regression	to	analyze	a	dichotomous	dependent	variable	[62]	(e.g.	opioid	abusers	vs.	non-abusers).	Some	of	the	studies	preliminarily	analyzed	variables	in	bivariate	analysis,	with	the	significant	variables	ultimately	entered	into	the	multivariate	model.	
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Table	2.1	Most	commonly	used	variables	in	statistical	models	to	predict	opioid	abuse	
Category	 Variable	
Interpretation	(Risk	=	
Opioid	abuse)	
#	of	
models	
Times	it	was	
protective	
Times	it	was	
risk	factor	
Odds	not	
reported	or	=	
exactly	1	Demographics	 Age	 Older	age	decreases	risk	 9	 9	 0	 0	Demographics	 Gender	 Male	increases	risk	 9	 0	 6	 3	Behavior	 History	of	ethanol	abuse	 Alcohol	abuse	increases	risk	 5	 1	 3	 1	Behavior	 Smoking	status	 Smoking	increases	risk	 5	 0	 4	 1	Mental	 Mental	health	diagnosis	 Mental	disorder	increases	risk	 5	 0	 4	 1	Medications	 #	of	opioid	prescriptions	 Increase	number	of	opioid	prescription	increases	risk	 4	 0	 4	 0	Behavior	 Early	refills	of	opioid	prescriptions	 Increase	number	of	early	refills	of	opioid	prescription	increases	risk	 4	 0	 4	 0	Medications	 Non-opioid	substance	abuse/dependence	 Non-opioid	substance	abuse/dependence	increases	risk	 4	 0	 4	 0	Care	utilization	 Inpatient	hospitalization	days	 Greater	hospitalization	days	increases	risk	 3	 0	 3	 0	Care	utilization	 Days	with	physical	care	visits	 Greater	outpatient	visits	increases	risk	 3	 0	 3	 0	Behavior	 #	of	pharmacies	where	opioid	prescription	were	filled	 Greater	number	of	pharmacies	where	opioid	prescription	were	filled	increases	risk	
3	 0	 3	 0	
Behavior	 #	of	opioid	prescribers	 Greater	number	of	opioid	prescription	increases	risk	 3	 0	 3	 0	Medications	 Methadone	 Presence	of	methadone	prescription	increases	risk	 3	 1	 2	 0	Medications	 Fentanyl	(IR)	 Presence	of	fentanyl	prescription	has	no	effect	on	risk	 3	 1	 1	 1	Medications	 Fentanyl	(ER)	 Presence	of	Fentanyl	(ER)	prescription	increases	risk	 3	 0	 2	 1	
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Category	 Variable	
Interpretation	(Risk	=	
Opioid	abuse)	
#	of	
models	
Times	it	was	
protective	
Times	it	was	
risk	factor	
Odds	not	
reported	or	=	
exactly	1	Medications	 Morphine	(IR)	 Presence	of	morphine	prescription	increases	risk	 3	 0	 2	 1	Medications	 Morphine	(ER)	 Presence	of	Morphine	(ER)	prescription	increases	risk	 3	 0	 2	 1	Medications	 Hydromorphone	 Presence	of	Hydromorphone	prescription	has	no	effect	on	risk	 3	 1	 1	 1	Medications	 Oxycodone	 Presence	of	Oxycodone	prescription	decreases	risk	 3	 1	 0	 2	Medications	 Tramadol	 Presence	of	Tramadol	prescription	decreases	risk	 3	 3	 0	 0	Medications	 Codeine	 Presence	of	Codeine	prescription	decreases	risk	 3	 2	 0	 1	Medications	 Propoxyphene	 Presence	of	Propoxyphene	prescription	decreases	risk	 3	 2	 0	 1	Medications	 Hydrocodone	 Presence	of	Hydrocodone	prescription	decreases	risk	 3	 2	 0	 1	Medications	 Morphine	(ER)	 Presence	of	Morphine	(ER)	prescription	increases	risk	 3	 0	 2	 1	Medications	 Fentanyl	(ER)	 Presence	of	Fentanyl	(ER)	prescription	increases	risk	 3	 0	 2	 1	Medical	Comorbidities	 Hepatitis	 Presence	of	Hepatitis	diagnosis	increases	risk	 3	 0	 3	 0	
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 Outcome	Definition	The	 examined	 articles	 defined	 the	 outcome	 of	 opioid	 abuse	 differently.	Specifically,	4	out	of	7	articles	(6	out	of	9	models)	depended	primarily	the	on	presence	or	 absence	of	 an	opioid	 abuse	or	dependence	diagnosis	 according	 to	 ICD-9	 codes,	while	the	other	2	studies	used	a	predefined	list	of	opioid-related	aberrant	behaviors.	Additionally,	 they	 also	 reviewed	 a	 patient’s	 profile	 for	 any	 release	 from	 the	 pain-management	 program	 due	 to	 aberrant	 behaviors.	 The	 last	 article	 and	 respective	model,	used	a	hybrid	technique	that	included	natural	language	processing	methods,	along	with	ICD-9	codes	to	define	opioid	problems	(Table	2.3).	[55–61]	
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Table	2.2	Outcome	definition	and	methods	data	source	
Article/	#	of	Models	 #	of	Patients	 Study	sample	 Source	of	data/Period	 Coding	Lewis,	2014/1	 202	 Prescriptions	of	an	opioid	for	30	or	more	days	of	consecutive	dosing.	Age	greater	than	18	years,	and	a	documented	history	of	any	chronic	pain	syndrome	defined	as	pain	lasting	greater	than	90	days	in	duration.	
Electronic	Health	Record/12	Months	 Manual	Chart	review	
Ives,	2006/1	 196	 chronic,	non-cancer	pain	of	at	least	three	months	duration	 Medical	record	and	our	disease	management	program	database/12	months	 Followup	White,	2009/2	 632,000	 12	to	64	years	with	at	least	1	claim	for	a	prescription	opioid	and	at	least	1	medical	claim	from	2005	to	2006.	 Administrative	claims	data/3	months	(Alternative	A)	&	12	months	(Alternative	B)	 ICD-9-	CM	White,	2012/2	 1,552,489	 Patients	ages	12-64	years	throughout	the	12	months	prior	to	the	index	opioid	Rx	 Administrative	claims	data/	12	Months	 ICD-9-	CM	Edlund,	2007/1	 15,160	 Veterans	with	at	least	one	prescription	for	an	opioid	and	had	more	than	91	days	of	supply	in	2002.	(excluded	individuals	with	any	cancer	diagnosis	(ICD-9-CM	codes	between	140.0	and	208.9)	
Administrative	claims	data/	24	months	 ICD-9-	CM	
Turner,	2014/1	 5,420	Urine	Drug	tests	 Patient	Age	20	or	above.	Study	included	only	Urine	Drug	Test	(UDTs)	for	patients	on	Chronic	opioid	therapy	(COT)	defined	by	Group	Health	as	70	days	opioid	supply	in	the	prior	90	day.	To	limit	the	sample	to	UDTs	for	CNCP	patients,	the	study	excluded	those	of	patients	who,	in	the	one-year	period	prior	to	the	UDT,	had	had	hospice	care,	opioid	prescriptions	from	oncologists,	or	more	than	one	visit	for	cancer	other	than	non-melanoma	skin	cancer.	
Electronic	Health	Record/	12	months	 ICD-9	
Hylan,	2015	 2,752	 18	years	or	older	who	initiated	COT	for	noncancer	pain	between	2008	&	2010.	COT	was	defined	as	receipt	of	equal	or	more	than	70	days	supply	of	transdermal	or	oral	opioids	(except	buprenorphine)	in	a	calendar	quarter,	which	corresponded	to	>75%	of	the	days	in	the	quarter	covered	by	an	opioid	prescription.	Study	patients	receive	at	least	2	quarters	of	COT	within	a	1-year	period	
ICD-9	codes:	304	[0,	.00,	.01,	.02;	304.7,	.70,	.71,	.72];	305	[5,	.50,	.51,	.52]	 ICD-9	+	Natural	Language	Processing	(NLP)	to	identify	[overuse,	misuse,	abuse	or	ad-	diction]	And/	or	[Dependance]	
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Table	2.3	Outcome	definition	and	methods	data	source	
Article	/#	of	
Models	 Outcome	Definition	Lewis,	2014/1	 multiple	pharmacies,	multiple	non	Belleville	Family	Health	Center	(BFHC)	prescribers	of	opioids	(any	prescription	preceded	 and	 followed	 by	 a	 BFHC	 provider	 prescribed	 opioid),	 unsanctioned	 dose	 escalation,	 lost	 or	 stolen	prescription,	 UDS	 anomalies,	 illicit	 drug	 use	 (either	 self-reported	 or	 identified	 via	 UDS),	 multiple	 emergency	department	visits	resulting	in	receipt	of	opioids,	family	report	of	opioid	sale	or	other	form	of	diversion,	Forging	or	tampering	with	controlled	substance,	prescriptions	and	misuse/adulteration	of	prescribed	formulation	or	intended	route	of	administration.	Ives,	2006/1	 Negative	urine	toxicological	screen	(UTS)	for	prescribed	opioids,	UTS	positive	for	opioids	or	controlled	substances	not	prescribed	by	our	practice,	Evidence	of	procurement	of	opioids	from	multiple	providers,	Diversion	of	opioids	Prescription	forgery	,	Stimulants	(cocaine	or	amphetamines)	on	UTS.	White,	2009/2	 304.0	(opioid-type	dependence),	304.7	(combinations	of	opioid	type	with	any	other),	305.5	(opioid	abuse),	or	965.0	(poisoning	by	opiates	or	related	narcotics	but	excluding	965.01	[heroin	poisoning])	White,	2012/2	 ICD	9	codes:	304.0,	304.7,	305.5,	965.00,	965.02,	and	965.09	
Edlund,	2007/1	 ICD	9	codes:	304.00304.03	(opioid	dependence),	304.70304.73	(dependence;	combinations	of	opioid	type	drug	with	any	other),	and	305.50305.53	(opioid	abuse)	Turner,	2014/1	 Clinical	Classification	Software	(CCS)	categorization.	Smoking	Status	used	305.1	ICD-9	code.	Hylan,	2015	 ICD-9	codes:	304	[0,	.00,	.01,	.02;	304.7,	.70,	.71,	.72];	305	[5,	.50,	.51,	.52]	
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 Discussion	
 Inconsistency	of	Prediction	Direction	of	Variables	Of	note,	we	found	inconsistency	in	the	ability	of	individual	variables	to	predict	the	outcome	(aberrant	drug-related	behavior).	Some	variables,	such	as	using	methadone	(for	opioid	use	disorder	treatment)	were	significant	risk	factors	in	two	models	(OR=	2.97,	CI=	2.57-3.42,	p-value	<	0.0001)	and	(OR=	3.22,	CI=	2.62-3.95,	p-value	<	0.0001),	and	significantly	protective	factor	in	a	third	model	(OR=	0.26,	CI=	0.08-0.94,	p-value	=	0.02).	A	second	example	is	seen	with	the	variable	history	of	alcohol	abuse.	Despite	a	predominance	in	the	literature,	which	shows	that	a	history	of	alcohol	abuse	is	a	risk	factor	 (4	 studies),	 the	 same	 variable	was	 slightly	 protective	 in	 a	 fifth	model.	 This	variation	 in	 the	 role	 of	 a	 predictive	 variable	 (protective	 vs.	 risk	 factor)	might	 be	solved	by	having	a	wider	measurement	scale	(continuous	or	multiple	categories)	for	the	variables	instead	of	a	dichotomous	scale	(Yes	or	No).	To	support	this	argument,	Zale,	E.	et.	al.,	2014,	conducted	the	first	study	of	its	kind	to	test	whether	varying	levels	of	 current/historical	 smoking	 and	 indices	 of	 smoking	 heaviness/nicotine	dependence	 may	 be	 associated	 with	 greater	 likelihood	 of	 past-year	 prescription	opioid	misuse	in	the	general	population.	[63]	The	study	found	a	positive	association	between	 level	of	 smoking	heaviness/nicotine	dependence	and	opioid	misuse	 [63].	Other	 variables,	 such	 as	 gender,	 number	 of	 opioid	 prescriptions,	 early	 refills,	inpatient	hospitalization	days,	days	with	physical	care	visits,	non-opioid	substance	abuse/dependence,	 number	 of	 morphine	 prescriptions,	 and	 number	 of	 opioid	prescribers	were	all	consistent	risk	factors	across	the	models.	Other	variables,	such	
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as	 age	 (older	 groups)	 and	 tramadol	 use,	were	 consistently	 reported	 as	 protective	variables	(Table	2.1).	
 Claims	Data	vs.	Electronic	Health	Record	Data	Using	a	specific	type	of	database	(administrative	claims	data	vs.	electronic	health	record	data)	could	potentially	alter	development	of	the	model	design.	For	example,	administrative	claim	databases	generally	provide	a	consistent	data	format,	because	they	use	a	pre-defined	set	of	codes,	[64]	As	result,	 it	 is	relatively	easier	to	create	a	study	 cohort	 using	 a	 claims	 data	 compared	 to	 most	 electronic	 health	 records	databases.	However,	one	potential	disadvantage	of	using	claims	data	is	that	the	care	providers	 do	 not	 always	 document	 these	 relevant	 codes.	 This	 incomplete	documentation	leads	to	missing	outcomes	of	interest	for	some	patients.	[65,66]	On	the	 other	 hand,	 using	 electronic	 health	 record	 databases,	 which	 has	much	 richer	clinical	 data	 (for	 each	 patient),	 [64]	 can	 facilitate	 improved	 cohort/outcome	definitions.	Specificity	within	the	cohort	can	be	achieved	by	reviewing	some	aspects	of	the	patient’s	file	manually	or	using	some	advanced	tools	to	define	the	study	cohort	based	on	certain	metrics	(e.g.,	estimated	glomerular	filtration	rate	to	define	chronic	kidney	failure	patients)	[64].	
 Variation	in	Outcome	Definition	The	 International	Classification	of	Diseases	(ICD)	 is	a	diagnostic	coding	system	that	 can	be	used	 to	 categorize	patients.	However,	 the	 issue	with	 creating	 a	model	based	 on	 an	 outcome	 structured	 by	 ICD	 codes	 is	 the	 fact	 that	 these	 codes	 often	understate	the	actual	number	of	patients	exhibiting	the	target	categorization	[57,58].	
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This	means	those	patients	who	are	labeled	with	opioid	problems,	according	to	ICD	codes,	are	likely	to	have	an	opioid	problem;	however,	ICD	codes	may	overlook	other	patients	who	have	opioid	problems	but	were	not	documented	[57].	This	could	be	due	an	 intentional	 lack	 of	 documentation,	 or	 in	 other	 cases,	 prescribers	 try	 to	 avoid	stigmatizing	 patients	 with	 opioid	 problems	 using	 these	 codes.	 [57]	 The	 issue	 of	underdocumentation	 in	 particular	 can	 create	 less	 representative	models.	 Another	limitation	to	the	models	found	is	the	fact	that	most	of	these	models	were	based	on	claims	 data,	which	 is	 less	 likely	 to	 provide	 the	 in-depth	 and	detailed	 clinical	 data	available	 in	 an	 electronic	 health	 record	 database.	 The	 variation	 in	 the	 outcome	definition	 across	 studies	 and	 its	 potential	 effect	 can	 be	 noticed	 in	 the	 self-report	opioid	risk	assessment	tools,	as	well.	When	tools,	such	as	SOAPP-R	(SOAPP	revised)	or	ORT	are	validated	across	different	populations	or	when	different	definitions	of	the	outcome	are	used,	the	prediction	sensitivity	and	specificity	changes	greatly.	SOAPP-R	 is	 a	 self-report	 questionnaire	 designed	 to	 predict	 aberrant	 medication-related	behaviors	among	persons	with	chronic	pain	[67].	SOAPP-R	came	as	a	revised	version	for	the	original	SOAPP,	an	instrument	developed	by	Inflexxion,	(Newton,	MA,	USA)	with	support	from	Endo	Pharmaceuticals	and	the	National	Institute	on	Drug	Abuse	[68].	Version	1,	considered	as	an	initial	step	toward	development	of	a	screener	for	aberrant	medication-related	behaviors	in	chronic	pain	patients	[37].	SOAPP-R	is	one	of	 the	 most	 validated	 tools;	 based	 on	 literature,	 there	 is	 a	 large	 variation	 in	 its	sensitivity.	The	sensitivity	and	specificity	of	SOAPP	were	91%	and	69%,	respectively,	in	 one	 study	 [42],	 and	 39.2%	 and	 69.3%,	 respectively,	 in	 another	 [43].	 The	 same	statement	can	be	applied	to	ORT,	as	well.	One	study	reported	sensitivity	of	45%	[46]	
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and	the	other	study	reported	sensitivity	as	low	as	19.5%	[43].	One	way	to	explain	the	variation	in	opioid	risk	assessment	tools	performance	could	be	due	to	a	difference	in	outcome	 definitions	 in	 the	 reviewed	 validation	 studies.	 For	 example,	 SOAPP	performance	 was	 measured	 in	 some	 studies	 based	 on	 a	 positive	 result	 on	 the	Aberrant	 Drug	 Behavior	 Index	 (ADBI)	 [67–69];	 while	 in	 other	 studies,	 it	 was	measured	based	on	the	presence	of	a	discharge	review	form	[70].	At	present,	such	cross-comparisons	for	opioid	risk	assessment	models,	which	are	based	on	databases,	are	not	yet	possible	due	to	a	lack	of	further	validation	from	multiple	studies	for	any	of	the	models	found.	However,	this	review	indicates	that	more	effort	in	the	future	is	likely	 to	utilize	secondary-data	analysis.	This	 is	due	to	 the	necessity	of	developing	more	 accurate	 and	 comprehensive	models	 from	 current	 and	 future	health	 system	electronic	records.	However,	these	future	efforts	will	surely	face	an	interesting	challenge,	considering	that,	as	of	2016,	most	of	 the	organizational	data	are	unstructured,	and	health	care	data	is	no	exception.	According	to	IBM,	in	2015,	unstructured	data	represented	80%	of	 the	 total	 health	 data.	 [71]	 Thus,	 it	 is	 important	 for	 future	 efforts	 to	 utilize	 the	untapped	potential	of	unstructured	data	to	develop	an	opioid	addiction	model	that	uses	data	mining	techniques.	Another	aspect	of	defining	outcomes	is	the	cohort	follow-up	period.	Whether	the	studies	retrieved	were	retrospective	or	prospective,	the	covered	period	to	measure	the	outcome	ranged	from	3	months	in	one	model,	including	12	months	in	6	models,	up	 to	24	months	 in	one	model,	and	 finally	24-60	months	(a	combination	of	a	pre-indexing	period	and	post-indexing	period).	This	variation	in	the	period	of	follow	up	
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might	have	an	unforeseeable	 impact	on	the	prediction	accuracy	of	the	models.	For	example,	a	period	of	3	months	of	 follow-up	may	not	be	sufficient	to	detect	opioid-related	aberrant	behaviors.	Thus,	patients	might	be	categorized	false	negative	as	a	result.	
 Limitations	There	are	only	7	studies,	including	9	models,	that	met	our	inclusion	criteria.	This	could	be	due	to	using	only	one	search	engine,	OVID	Medline.	However,	 the	study’s	search	terms	were	exhaustive	and	used	results	from	combined	3	search	sessions	to	mitigate	 this	 shortcoming	 (Figure	 2.1).	 Another	 reason	 for	 the	 relatively	 small	number	of	articles	is	the	exclusion	of	self-report	opioid	risk	assessment	methods	(21	articles).	The	justification	for	omitting	these	articles	is	specific	to	the	study	questions.	The	study	attempts	to	identify	variables	and	resources	used	for	the	design	of	models	based	on	databases,	electronic	health	records,	and	administrative	claim	data.	Another	limitation	 related	 to	 data	 collection	 is	 having	 only	 one	 primary	 care	 physician	 to	check	for	face	validity	and	data	consistency.	Having	another	reviewer	and	reporting	interrater	reliability	could	add	value	to	the	study.	In	our	case,	this	was	not	feasible,	due	to	limited	funds	and	resources	available	for	the	study.	A	second	limitation	pertains	to	the	quantitative	analysis	of	the	variables	found,	which	did	not	include	magnitude	of	the	odd	ratio	or	significance	of	p-values	for	each	variable.	Rather,	the	analysis	only	describes	a	variables	rule	in	terms	of	being	a	risk	factor	or	protective	measure	(Table	2.1).	This	was	due	 to	a	 lack	of	 reporting	odds	ratios	in	2	articles	and	p-value	data	in	a	third	article.	These	2	articles	did	not	report	the	odds	data	for	the	insignificant	variables,	while	the	third	article	did	not	report	any	
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p-values	for	the	model	(but	reported	adjusted	OR	and	CI,	instead).	Finally,	the	way	articles	categorized	the	variables	subset	varied	across	the	model.	For	example,	the	variable	 age	 was	 sub-categorized	 into	 6	 age	 groups,	 while	 it	 was	 treated	 as	 a	continuous	variable	in	the	other.	Moreover,	determining	the	reference	group	varied	among	 models,	 as	 well.	 In	 the	 same	 example	 of	 the	 variable	 “Age”,	 one	 model	identified	an	older	age	sub-group	as	a	reference	group,	while	5	models	identified	a	younger	age	sub-group	as	a	reference,	and	one	article	identified	middle	age	(40-49)	as	a	reference	group.	A	 third	 limitation	 of	 this	 review	 is	 the	 inconsistency	 in	 the	 definition	 of	 the	outcome,	opioid	abuse,	across	the	articles.	Despite	a	description	and	analysis	of	the	same	issues,	the	particular	definitions	employed	varied	across	articles.	Shannon	M.	Smith	et	al	examined	 the	 issue	of	definition	 inconsistency	 in	2013.	 [72]	The	study	summarized	differences	between	multiple	opioid-use-disorder	terminologies	based	on	experts’	opinion.	The	study	found	that	the	term	“misuse”	“emphasizes	the	use	of	the	 substance	 does	 not	 follow	 medical	 indications	 or	 prescribed	 dosing”	 [72].	However,	the	term	“abuse”	is	commonly	applied	to	substance	use	for	nontherapeutic	purposes.	Addiction,	on	the	other	hand,	was	defined	as	“compulsive	substance	use	that	occurs	despite	personal	harm	or	negative	consequences”	[72].	To	address	this	variation	 of	 the	 definition	 in	 the	 examined	 articles,	 we	 summarized	 outcome	definitions	by	each	article	in	Table	2.3.	Our	analysis	was	limited	to	the	data	provided	in	the	articles.	Thus,	access	to	certain	data	that	measured	the	models	performance,	such	 as	 c-statistics,	 sensitivity,	 and	 specificity	 for	 analyzed	 models,	 were	 not	available.	 	
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 Conclusion	Opioid	risk	assessment	tools	are	becoming	standard	practice	in	pain	and	primary	clinics	prior	and	during	prescribing	opioid	therapy	for	chronic	pain.	However,	this	review	 indicates	 that	 there	 is	 inter/intra	variation	 in	 these	 tools’	performance	 for	assessing	opioid	abuse.	This	review	concludes	that	this	variation	can	be	explained	by	the	variation	in	study	period,	sample	size,	opioid	abuse	definition,	type	of	database,	and	 structured	documentation	 to	 ICD	codes.	 In	addition,	 this	 review	 illustrates	an	overview	of	common	methods	of	opioid	risk	assessment	tools	and	categorizes	them	based	 on	 method	 of	 reporting	 into	 self-report	 and	 database-related	 models.	Moreover,	the	study	provides	a	comparison	Between	the	two	categories	whenever	possible.	This	systematic	review	presents	a	list	of	variables	that	were	used	to	predict	opioid	abuse	from	electronic	health	records	and	administrative	data.	Furthermore,	the	review	provided	a	count	of	how	many	times	each	variable	was	mentioned	and	how	often	it	was	counted	as	a	risk	factor	or	protective	measure	in	the	literature.	To	our	knowledge,	this	is	the	only	systematic	review	that	has	done	so.	Providing	such	data	to	researchers	could	lead	to	developing	a	tool	that	is	more	accurate	in	predicting	the	risk	of	developing	aberrant	drug-related	behaviors.	The	review	also	identifies	and	compares	 other	 aspects	 related	 to	 opioid	 risk	 assessment	models	 design,	 such	 as	period	of	 the	 study,	number	of	patients,	 subject	 inclusion	 criteria,	 and	 ICD-9	 code	used	to	identify	patients	from	the	database.	The	study	highlights	major	differences	between	articles	defining	opioid	 abuse	derived	 from	databases	 for	 the	purpose	of	developing	opioid	use	risk	assessment	tools.	This	could	help	future	researchers	build	on	previous	work	to	create	advanced	models	for	 improved	predictability	of	opioid	
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abuse.	 Despite	 the	 availability	 and	 presence	 of	 many	 self-report	 and	 database-oriented	risk	assessment	tools,	prescribers	might	not	yet	rely	solely	on	these	tools	due	to	their	lack	of	validation	and	consistency	in	their	results.	However,	opioid	risk	assessment	procedures	can	be	improved	by	enhancing	structured	data	captured	by	the	electronic	health	record	system.	Physicians	and	nurses	can	play	a	major	role	in	this	step	by	documenting	the	proper	ICD	code	that	specifically	identifies	the	category	of	opioid	abuse	for	patients.	Clinical	practices	and	hospitals	should	pay	attention	to	the	viability	of	 adopting	 these	 tools	 into	 their	practice.	 Some	expected	barriers	 to	adoption	of	these	tools	are:	the	population	variation	from	within	the	clinic	where	the	tool	was	validated,	procedural	differences,	differences	in	outcome	definition	between	clinics,	and	lack	of	proper	technical	experience	to	implement	these	tools.	 	
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3. IDENTIFY	AND	COMPARE	PATIENTS	WITH	OPIOID	USE	PROBLEM	
 	 Introduction	Opioids	are	a	group	of	medications	prescribed	to	relieve	pain.	Before	the	1980s	these	drugs	were	mainly	prescribed	by	surgeons	to	relieve	immediate	postoperative	pain	or	pain	related	to	cancer	[73,74].	However,	during	the	1980s,	the	move	toward	aggressive	pain	treatment	and	prescribing	opioids	for	chronic	non-cancer	pain	has	been	 encouraged	 [73,75].	 Advocacy	 health	 groups,	 such	 as	 American	 Pain	Foundation,	continued	to	push	for	more	opioid	prescriptions	during	the	late	1990s	and	through	the	2000s	[73,76–78].	By	2012,	opioid	prescriptions	increased	from	142	million	in	1999	to	248	million	prescriptions	[79,80]	and	opioid	sales	quadrupled	from	1999	 to	 2010	 [81].	 Particular	 medications,	 such	 as	 hydrocodone,	 doubled	 in	consumption	between	1999	and	2011	[82].	In	conjunction	with	the	increase	in	prescribed	opioids	per	population,	there	was	also	 a	 higher	 percentage	 of	 opioid	 overdose	 deaths	 and	 substance	 use	 disorder	treatment	 increased	 in	 parallel	 from	 1999	 to	 2008	 [19].	 In	 2015,	 drug	 overdose	incidents	accounted	for	52,404	U.S.	deaths,	of	which	opioids	were	involved	in	33,091	overdose	incidents	(63.1%)	[83].	The	2016	National	Survey	on	Drug	Use	and	Health	indicated	that	there	was	approximately	11.8	million	people	in	the	U.S.	age	12	years	or	older	who	misused	 opioids	 in	 the	 past	 year	 [24].	 At	 the	 state	 level,	 Indiana	 state	reported	794	opioid-related	overdose	deaths	with	a	substantial	increase	in	heroin-related	 overdose	 deaths.	 Compared	 to	 2012,	 heroin-related	 overdose	 deaths	increased	from	114	to	297	in	2016.	Deaths	from	synthetic	opioids	have	increased	for	the	same	period	from	43	to	304	deaths	in	Indiana	[84].	
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Despite	 the	 importance	 of	 the	 opioid	 issue,	 reporting	 prevalence	 of	 opioid	problems	may	still	impose	some	challenges.	For	example,	differences	in	the	targeted	outcome	definitions	(“opioid	use	disorder”	vs.	“opioid	overdose”	vs.“opioid	abuse”)	and	population	inclusion	criteria	(minimum	medication	day’s	supply	or	number	of	opioid	prescriptions)	may	alter	the	study’s	ability	to	identify	the	issue	[85].	Despite	these	differences,	International	Classification	of	Disease	(ICD)	identification	may	be	a	standard	method	that	may	used	to	report	opioid	use	disorder,	overdose,	abuse,	and	dependence	(which	we	will	refer	to	in	this	study	as	Opioid	Use	Problem	(OUP)).	ICD	is	a	code	system	used	by	physicians	to	classify	and	diagnose	disease.	However,	the	issue	with	reporting	an	outcome	defined	by	 ICD	codes	 is	 the	 fact	 that	 these	codes	often	understate	the	actual	number	of	patients	exhibiting	the	target	categorization	[57,58].	Thus,	we	examined	the	literature	to	identify	alternative	methods	to	identify	opioid	use	problem	 in	 addition	 to	 ICD	 codes.	We	 found	 a	 limited	number	of	 studies	 that	discuss	alternative	methods	using	natural	language	processing	(NLP),	or	text	mining,	in	a	general	healthcare	setting	[86–89].	The	use	of	text	mining	in	these	studies	varied	from	 accelerating	 the	 documentation	 process	 of	 patient	 records	 to	 automatically	parsing	 and	 coding	 clinical	 events	 or	 assisting	 decision-making	 processes	 by	classifying	specific	complex	diagnoses.	More	 relevant	 studies	 addressing	 NLP/text	 mining	 to	 identify	 opioid	 use	problems	were	identified	as	well	[61,90,91].	Carrell	et	al.	(2015)	developed	an	NLP	process	 to	 identify	 evidence	 of	 opioid	 use	 problems	 in	 electronic	 health	 records	(EHRs)	at	Group	Health,	a	healthcare	system	in	Seattle,	WA,	USA.	The	study	found	that	
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conventional	diagnostic	codes	for	opioid	use	problems	has	identified	2,240	(10.1%)	patients	and	NLP	identified	an	additional	728	(3.1%)	patients	by	analyzing	patients’	clinical	notes	[90].	Hylan	et	al.	(2015)	has	also	used	NLP	to	“report	on	a	predictive	model	developed	to	assess	the	likelihood	of	problem	opioid	use	over	a	2-	to	5-year	period	following	initiation	of	chronic	opioid	therapy”	within	the	Group	Health	system.	The	study	found	the	sensitivity	of	the	regression	model	prediction	of	problem	opioid	use	to	be	58.3%,	with	specificity	being	71.2%	[61].	Despite	these	early	efforts	of	to	use	 NLP/text	 mining	 encouraging,	 no	 study	 has	 attempted	 to	 identify	 opioid	 use	problems	using	text	mining	in	a	multi-site	study	setting.	In	 this	 study,	 we	 compared	 different	 strategies	 for	 identifying	 OUP	 using	administrative	and	EHR	data.	We	examined	whether	adding	a	text	mining	approach	could	improve	identification	of	OUP	for	patients	on	long-term	opioid	therapy	(LTOT)	for	a	large	population	across	a	multi-site	healthcare	system.	
 Method	
 Methods	Overview	Following	Institution	Review	Board	(IRB#:	1710876219)	and	an	approval	from	the	Regenstrief	Institute	(RI)	Data	Management	Committee,	we	queried	identified	the	patients’	 clinical	 notes	 from	 Indiana	 University	 Health	 (IUH),	 a	 large	 healthcare	network	in	Indiana	with	3,541	staffed	beds	and	2,563,086	outpatient	visits	[92].	The	IUH	system	produces	over	30	report	types	(e.g.,	Visit	notes,	Progress	notes,	Discharge	notes).	Next,	 a	 text-mining	 algorithm	was	 applied	 to	 identify	 opioid	use	problems	using	patients’	clinical	notes	and	reported	incidence	results	(Figure	3.1).	Finally,	to	investigate	whether	or	not	there	was	a	difference	between	positive	OUP	using	a	text	
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mining	 approach	 vs.	 an	 ICD	 conventional	 approach,	 we	 compared	 the	 2	 positive	cohorts	 characteristics	 in	 terms	of	 frequency	 and	 rate	per	1,000	 long-term	opioid	therapy	patients	 and	highlighted	key	points.	Additionally,	we	 compared	 results	 of	care	 utilization	 (outpatient	 visits,	 emergency	 department	 visits,	 hospitalizations,	cumulative	hospitalization	days)	and	they	were	also	reported.	
 Sample	Definition	Our	sample	was	defined	as	adult	IUH	members	age	18	years	or	older	who	have	been	prescribed	LTOT,	which	is	defined	as	patients	with	70	days	of	supply	within	any	given	90-day	period	between	1	January	2013	and	31	December	2014	(24	months).	We	excluded	patients	with	active	cancer	to	focus	on	LTOT	for	non-cancer	chronic	pain	(ICD-9	 codes	 140.x	 172.x,	 174.x	 209.xx,	 235.x	 239.xx,	 338.3).	 Patients	 with	schizophrenia	were	also	excluded	due	to	the	documented	high	percentage	of	opioid	dependence	among	this	population	(ICD-9	code	295.9)	[93].	
 Variables	of	Interest	Patient	characteristics,	including	demographics	(age,	gender,	race,	and	ethnicity),	alcohol	abuse,	non-opioid	abuse,	tobacco	use,	mental	disorders,	and	hepatitis	C	were	reported	 for	 the	 study	 population.	 For	 this	 study,	 mental	 health	 disorders	 were	identified	as	depressive	disorder	 (ICD-9	codes	296.2x,	296.3x,	300.4,	311),	 suicide	attempt	or	other	self-injury	(ICD-9	codes	E95x.x,	E98x.x),	or	anxiety	disorder	(ICD9	codes	300.0x,	300.21,	300.22,	300.23,	300.3,	308.3,	309.81).	
 Report	Type	Selection	Due	to	the	large	number	of	report	types	generated	by	IUH	systems,	we	focused	on	the	most	prevalent	 and	 relevant	note	 types	 available	 in	 the	database.	To	 increase	
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efficiency,	the	text	mining	process	was	limited	to	report	types	that	were	objectively	deemed	relevant	to	OUP	identification	through	consulting	clinical	and	data	subject	experts	at	 Indiana	University	and	 the	Regenstrief	 Institute.	Three	 types	of	 reports	were	initially	excluded	due	to	presumed	irrelevance	to	OUP	identification:	radiology	reports,	 medication	 fills,	 and	 patient	 instructions.	 Next,	 the	 study	 investigators	selected	9	report	types	with	assumed	relevancy	to	OUP	identification	and	queried	the	study	population	for	their	2014	counts.	The	system	returned	142,971	reports	as	the	following:	 Emergency	 Department	 Doctor	 Progress	 Notes	 (48,898),	 Emergency	Department	 Discharge	 Notes	 (28,637),	 Primary	 Care	 Doctor	 Outpatient	 Progress	Notes	 (26,669),	 Visit	 Notes	 (21,868),	 Discharge	 Summary	 (11,731),	 History	 and	Physical	 (2,759),	 Admission	 History	 &	 Physical	 (1,390),	 Preadmission	History/Physical	(576),	Primary	Care	Doctor	Outpatient	History	and	Physical	/Initial	Consult	(443).	By	exploring	the	9	relevant	report	types,	we	found	that	the	top	5	report	types	generated	over	96%	(137,802)	of	total	reports,	while	the	bottom	4	were	only	responsible	 for	 4%	 of	 reports	 generated.	 Due	 to	 labor	 constraints,	 the	 bottom	 4	reports	 (Admission	History	 and	 Physical,	 Preadmission	History/Physical,	 Primary	Care	Doctor	Outpatient	History	and	Physical	/Initial	Consult)	were	excluded.	Thus,	Emergency	Department	Doctor	Progress	Notes,	 Emergency	Department	Discharge	Notes,	 Primary	 Care	 Doctor	 Outpatient	 Progress	 Notes,	 Visit	 Notes,	 Discharge	Summary,	were	used	for	the	text-mining	analysis.	
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 Identify	Patients	with	Opioid	Use	Problems	We	used	two	criteria	which	are	explained	in	the	following	section	to	identify	opioid	use	problem.	The	criteria	will	cover	text-mining	and	ICD-9	approaches	which	are	explained	in	details	in	the	following	sections.		
Identify	OUP	using	a	Text	Miming	Process	The	 process	 of	 identifying	 OUP	 using	 text	 mining	 involved	 2	 main	 steps:	 1)	algorithm	 development	 to	 flag	 potential	 positive	 reports;	 and	 2)	 results	 of	 the	validation	process	using	semi-assisted	manual	review.	
1- Algorithm	Development	to	Flag	Potential	Positive	Cases	Using	nDepth™	We	applied	the	text-mining	package	provided	by	nDepth™	to	parse	medical	notes	to	detect	OUP.	nDepth™	is	an	NLP	tool	designed	by	the	Regenstrief	Institute	in	Indianapolis	to	extract	data	from	the	Indiana	Network	for	Patient	Care	(INPC),	which	is	a	healthcare	database	managed	by	Regenstrief	Institute	on	behalf	of	the	Indiana	Health	 Information	Exchange	(IHIE)	 [94,95].	As	 IUH	 is	part	of	 INPC,	nDepth™	was	used	 to	query	patients’	 clinical	 notes	 to	 identify	possible	opioid	use	problems.	To	develop	the	algorithm,	2	keyword	lists	adopted	from	the	literature	were	entered	into	nDepth™	[91].	The	first	list	was	comprised	of	opioid	terms	(e.g.,	Vicodin,	Opiate),	and	the	second	list	was	comprised	of	problem	terms	(e.g.,	addiction,	abuse)	(Appendix	A.1).	 nDepth™	 creates	 state	 machines,	 an	 algorithm	 that	 parses	 report	 types	 for	certain	criteria,	to	check	for	all	possible	combinations	of	the	2	lists	within	a	5-word	distance.	 Flagged	 results	 are	 automatically	 checked	 for	 whether	 the	 statement	 is	negated,	 hypothetical,	 historical,	 or	 experienced.	 This	 process	 itself	 was	 adopted	from	the	ConText	algorithm	developed	by	Harkema	et	al.	 (2009)	 [96].	Thus,	 if	 the	
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system	determined	the	patient	statement	was	not	negated	or	deemed	hypothetical	or	historical,	those	flags	were	deemed	as	experienced	(considered	positive).	
2- Semi-Assisted	Manual	Review	Validation	Process	Flagged	reports	were	semi-assisted	manual	reviewed	by	2	trained	reviewers.	In	case	of	disagreement,	an	expert	physician	acted	as	a	 third	reviewer	 to	resolve	 the	dispute.	 To	 avoid	 overlooking	 any	 signs	 of	 opioid	 use	 problems,	 nDepth™	 was	programmed	to	highlight	27	suggestive	phrases	in	the	flagged	reports.	These	phrases	were	collected	from	the	literature	and	modified	based	on	common	clinical	dialog	in	Indiana	(Appendix	A.2).	In	cases	where	there	was	more	than	one	flagged	report	per	patient,	the	system	randomly	selected	one	type	of	the	flagged	reports	to	be	reviewed	per	patient.	The	criteria	chosen	to	determine	OUP	were	adopted	from	Carrell	et	al.s’	(2015)	 work	 and	 listed	 in	 Table	 3.1.	 Of	 note,	 as	 using	 marijuana	 medically	 and	recreationally	is	illegal	in	Indiana,	its	use	was	treated	as	concurrent	use	of	an	illicit	drug	during	 the	process	of	manual	review.	Other	modifications	were	also	adopted	based	on	initial	reviews	of	subsets	of	patients’	clinical	reports.	
 Identify	OUP	Using	ICD-9	Codes	Two	definitions	from	the	literature	utilizing	ICD-9	codes	were	combined	to	create	a	 case	 definition	 of	 OUP:	 opioid	 abuse	 and	 dependence	 (304.00,	 304.01,	 305.50,	305.51,	304.71,	304.02	,	304.70,	305.52)	and	opioid	poisoning	(965.0,	965.00,	965.01,	965.02,	 965.09,	 E850.0,	 E850.1,	 E850.2)	 (Appendix	 A.3).	 These	 definitions	 were	combined	 to	 minimize	 the	 chance	 of	 systematically	 creating	 type	 II	 errors	 by	capturing	the	wider	spectrum	of	opioid	use	problems	among	the	study	population.		 	
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Table	3.1	The	criteria	for	identifying	opioid	use	problems	in	patients’	clinical	notes	
No.	 Criteria	for	opioid	use	problems	1	 Substance	abuse	treatment,	including	referral	or	recommendation	2	 Methadone	or	suboxone	treatment	for	addiction	3	 Obtained	opioids	from	nonmedical	sources	4	 Loss	of	control	of	opioids,	craving	5	 Family	member	reported	patient’s	opioid	addiction	to	clinician	6	 Significant	treatment	contract	violation	7	 Concurrent	alcohol	abuse/dependence	(not	remitted)	8	 Concurrent	use	of	illicit	drugs	9	 Current	or	recent	opioid	overdose	10	 Pattern	of	early	refills	(not	an	isolated	event)	11	 Manipulation	of	physician	to	obtain	opioids	12	 Obtained	opioids	from	multiple	physicians	surreptitiously	13	 Opioid	taper/wean	due	to	problems,	lack	of	efficacy	(not	due	to	expected	pain	improvement)	14	 Unsuccessful	taper	attempt	15	 Rebound	headache	related	to	chronic	opioid	use	16	 Concurrent	use	of	unauthorized	narcotics	(polypharmacy)	17	 Physician	states	opioid	abuse/overuse/addiction	or	listed	ICD	codes	for	opioid	abuse/dependence	
 Analysis	Frequency	tables	will	be	used	to	describe	studied	population	characteristics.	For	inferential	statistics,	characteristics	of	positive	OUP	identified	by	text	mining	and	ICD	cohorts	will	be	compared.	Chi-square	will	be	used	for	categorical	data	analysis	and	independent	t-test	will	be	used	to	compare	means	for	continuous	variables.	 	
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	Figure	3.1	Identification	of	opioid	use	problems	summary	methods	and	results		 	
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 Results	We	identified	and	compared	OUP	using	ICD-9	codes	and	text	mining	techniques.	The	results	are	summarized	in	Figure	3.1.	
 Sampling	Results	Adult	 patients	 from	 IUH	 on	 LTOT	 were	 queried,	 and	 our	 inclusion	 criteria	returned	34,661	patients.	Our	exclusion	criteria,	cancer	and	schizophrenia,	excluded	11,579	(33.4%)	patients	(11,121	cancer	patients,	272	with	schizophrenia	[186	with	both	schizophrenia	and	cancer]).	We	identified	23,082	patients	who	received	LTOT	and	generated	559,464	reports	across	the	IUH	system.	Our	report	selection	criteria	excluded	8,784	patients,	 leaving	14,298	eligible	patients	which	generated	137,804	reports.	Nearly	 60%	of	 the	 study	population	were	 over	 55	 years	 old,	 and	women	represented	62%	of	the	study	population.	The	white	race	was	dominant	among	the	study	 population	 (86%),	 while	 black	 patients	 represented	 12%,	 and	 other	 or	unknown	races	were	2%.	Non-Hispanic	or	Latino	ethnicity	represented	87%	of	the	study	population	(Table	3.2).	
 Identification	of	Opioid	Use	Problems	Using	a	Text-Mining	Approach	Our	algorithm	flagged	468	distinct	statements	in	366	unique	reports	representing	154	patients.	For	validation	and	to	confirm	the	presence	of	OUP,	2	reviewers	each	reviewed	1	flagged	report	per	positive	patient	based	on	specific	criteria	(Table	3.1).	Out	of	154	flagged	patients,	only	127	patients	were	deemed	as	positive	cases	of	OUP	with	a	positive	predictive	value	of	82%.	Cohen’s	κ	was	run	to	determine	if	there	was	agreement	between	2	reviewers’	judgement	on	whether	a	subset	of	200	patients	in	
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the	 study	 cohort	were	meeting	 any	OUP	 criteria.	 There	was	moderate	 agreement	between	the	2	reviewers	judgements:	κ	=	.0.691	(95%	CI,	0.58	to	0.79),	p	<	.0005.	Table	3.2	Demographics	characteristics	of	study	population	
Demographics	 Study	Cohort	N(%)	Age	(18-24)	 236	(1.7%)	25-34	 891	(6.2%)	35-44	 1,749	(12.2%)	45-54	 2,808	(19.6%)	55-64	 3,222	(22.5%)	
>65	 5,392	(37.7%)	Sex	(women)	 8,923	(62.4%)	Men	 5,375	(37.6%)	Race	(Black)	 1,719	(12.0%)	White	 12,367	(86.5%)	Other/Unknown	 212	(2.0%)	Ethnicity	(Not	Hispanic	or	Latino)	 12,369	(86.5%)	Hispanic	or	Latino	 138	(1.0%)	Unknown	 1,791	(12.5%)	Alcohol	Abuse	(Yes)	 88	(0.6%)	Non-opioid	Abuse	(Yes)	 88	(0.6%)	Tobacco	Use	(Yes)	 912	(6.4%)	Depression	(Yes)	 845	(5.9%)	Self-injury	(Yes)	 14	(0.1%)	Hepatitis	C	(Yes)	 94	(0.7%)	
Total	 14,298	Frequency	distribution	of	criteria	to	identify	OUP	in	patients’	clinical	notes	were	ranked	as	follows	[OUP	criteria,	Frequency	(percentage)]:	[Physician	states	narcotic	abuse/overuse/addiction	 or	 listed	 ICD	 codes	 for	 opioid	 abuse/dependence,	 48	(38%)];	 [Concurrent	 use	 of	 illicit	 drugs,	 18	 (14%);	 Methadone	 or	 suboxone	treatment	 for	 addiction,	 15	 (12%)];	 [Concurrent	 use	 of	 unauthorized	 narcotics	(polypharmacy),	 11	 (9%)];	 [Current	 or	 recent	 opioid	 overdose,	 10	 (8%)];	[Concurrent	alcohol	abuse/dependence	(not	remitted),	9	(7%)];	[Obtained	opioids	from	 multiple	 physicians	 surreptitiously,	 8	 (6%)];	 [Physician	 or	 patient	 wants	immediate	 taper,	 3	 (2%)];	 [Substance	 abuse	 treatment,	 including	 referral	 or	
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recommendation,	 2	 (2%)],	 [Significant	 treatment	 contract	 violation,	 2	 (2%)];	[Family	member	reported	patient’s	opioid	addiction	to	clinician,	1	(1%)]	
 Comparison	Between	Text	Mining	and	ICD-9	In	comparison	to	the	text-mining	approach,	querying	the	same	study	cohort	for	designated	ICD-9	codes	to	identify	OUP	returned	49	distinct	events	representing	45	unique	patients	(4	patients	had	2	distinct	positive	OUP	ICD-9	codes).	The	frequency	distribution	of	positive	ICD-9	codes	for	OUP	were	ranked	as	the	following	[ICD-9	code,	Frequency	(percentage)]:	[304,	24	(49%),	305.5,	9	(18%)],	[304.01,	5	(10%),	965,	3	(6%),	965.01,	3	(6%)],	[E850.2,	2	(4%)],	[304.71,	1	(2%)],	[965.09,	1	(2%)],	[E850.0,	1	(2%)]	(Appendix	A.4	and	Appendix	A.5).	The	overlap	between	the	2	OUP	positive	cohorts	was	measured,	and	we	found	8	cases	 that	were	positive	 in	both	a	 text	mining	approach	and	ICD-9	codes	query	(Appendix	A.1).	The	frequency	distribution	of	OUP	positive	cohorts	characteristics	are	summarized	in	Table	3.3.	The	frequency	distribution	percentage	of	positive	OUP	among	stratified	positive	cohorts	(ICD	and	text	mining)	by	gender	shows	that	women	had	a	higher	frequency	among	ICD	cohorts	compared	to	the	text	mining	cohort	(71%	and	48%).	However,	the	rate	of	overall	positive	OUP	indicates	a	higher	rate	of	positive	OUP	of	men	vs.	women	(14.7	vs.	10.4	per	1,000).	The	frequency	distribution	percentage	of	positive	OUP	among	stratified	positive	cohorts	(ICD	and	text	mining)	by	age	group	shows	that	the	45-54	age	group	had	the	highest	frequency	percentage	of	OUP	(31%	and	24%).	However,	the	rate	of	positive	OUP	per	group	age	indicates	the	18-24	group	age	had	the	highest	OUP	rate	among	
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age	groups	in	ICD	and	text	mining	cohorts	(12.7	and	42.4	per	1,000)	(Table	3.3	and	Figure	3.2).	Table	3.3	Frequency	distribution	of	OUP	positive	cohorts’	characteristics	
Characteristic	
Study	Cohorts*	 Significance	
ICD-9	N	(%)	
Text-Mining	N	
(%)	
Combined	N	
(%)	 X2	(P-value)**	Age	(18-24)	 3	(6.7%)	 10	(7.9%)	 13	(7.9%)	 10.2	(<	0.001)	†	25-34	 7	(15.6%)	 22	(17.3%)	 26	(15.9%)	 		35-44	 4	(8.9%)	 29	(22.8%)	 33	(20.1%)	 		45-54	 14	(31.1%)	 31	(24.4%)	 42	(25.6%)	 		55-64	 7	(15.6%)	 25	(19.7%)	 31	(18.9%)	 		>65	 10	(22.2%)	 10	(7.9%)	 19	(11.6%)	 		Sex	(Women)	 32	(71.1%)	 61	(48.0%)	 89	(54.3%)	 7.1	(0.0076)	†	Men	 13	(28.9%)	 66	(52.0%)	 75	(45.7%)	 		Race	(Black)	 5	(11.1%)	 23	(18.1%)	 27	(16.5%)	 1.6	(0.6014)	White	 39	(87.7%)	 101	(79.5%)	 134	(81.7%)	 		Other/Unknown	 1	(2.0%)	 3	(2.4%)	 3	(1.8%)	 		Ethnicity	(Not	Hispanic	or	Latino)	 39	(86.7%)	 106	(83.5%)	 139	(84.8%)	 0.8	(1)	Hispanic	or	Latino	 0	(0.0%)	 2	(1.6%)	 2	(1.2%)	 		Unknown	 6	(13.3%)	 19	(15.0%)	 23	(14.0%)	 		Other	Characteristics	Alcohol	Abuse	(Yes)	 2	(4.4%)	 3	(2.4%)	 5	(3.0%)	 0.5	(0.6069)	Non-opioid	Abuse	(Yes)	 10	(22.2%)	 7	(5.5%)	 14	(8.5%)	 10.4	(0.0028)	†	Tobacco	Use	(Yes)	 14	(31.1%)	 17	(13.4%)	 30	(18.3%)	 7	(0.0079)	Depression	(Yes)	 12	(26.7%)	 14	(11.0%)	 23	(14.0%)	 6.3	(0.0118)	†	Self-injury	(Yes)	 2	(4.4%)	 2	(1.6%)	 3	(1.8%)	 1.2	(0.2804)	Hepatitis	C	(Yes)	 3	(6.7%)	 3	(2.4%)	 5	(3.0%)	 1.8	(0.1848)	
Total	Cohorts	 45	 127	 164*	 —	*ICD-9:	 Positive	 OUP	 cases	 using	 ICD-9	 codes;	 Text	 Mining:	 Positive	 OUP	 cases	 using	 a	 text	 mining	approach;	Combined:	Combined	positive	cases	in	ICD-9	codes	or	a	text	mining	approach	(There	are	8	cases	that	overlapped	between	ICD	and	text	mining	cohorts);	(%):	Column	percentage.	**	Chi-square	was	reported	for	22	measurements	and	Fishers	exact	test	(Freeman-Halton	test)	for	r	x	c	tables.	†	Significant	difference	between	ICD	and	Text-mining	cohort	on	α	=	0.05.		Table	3.4	Comparison	of	care	utilization	among	OUP	positive	cohorts	
Care	Utilization	
ICD	Positive	
Mean	±	(SD)	
Text-mining	Positive	
Mean	±	(SD)	 P-value	Outpatient	Visits	 12.84	±(15.05)	 12.87	±	(12.402)	 0.992	Emergency	Department	visits	 1.91	±	(2.193)	 3.17	±	(4.915)	 0.022	†	Hospitalizations	 2.24	±	(2.838)	 1.55	±	(2.572)	 0.154	Cumulative	Hospitalizations	Days	 16.24	±(23.985)	 7.43±	(12.016)	 0.022	†	†	Results	are	significant	on	α	=	0.05	Similar	 to	 the	 overall	 study	 population,	 race	 and	 ethnicity	 were	 dominantly	White,	 non-Hispanic	 in	 both	 positive	 cohorts	 (Table	 3.3).	 Other	 characteristics	associated	with	OUP	in	the	literature	were	reported,	including	alcohol	abuse,	non-
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opioid	 abuse,	 tobacco	 use,	 depression,	 self-injury,	 and	 hepatitis	 C.	 All	 showed	 a	pattern	of	being	at	their	lower	point	in	the	negative	cohort,	with	a	modest	increase	in	the	positive	text-mining	cohort	and	peaking	at	the	positive	ICD-9	cohort	(Table	3.3).	 An	 independent-samples	 t-test	 was	 conducted	 to	 compare	 care	 utilization	(outpatient	 visits,	 emergency	 department	 visit,	 hospitalizations,	 cumulative	hospitalization	days)	among	OUP	positive	 cohorts	 (Table	3.4).Our	analysis	 shows	that	 positive	 text	 mining	 cohort	 had	 significantly	 higher	 average	 of	 visiting	emergency	department	(M	=	3.17,	SD=	4.9)	comparing	to	ICD	positive	cohort	(M	=	1.9,	SD=	2.1),	P	=	0.022.	The	ICD	positive	cohort	had	a	significantly	higher	average	of	cumulative	hospitalization	days	(M	=	16.2,	SD=	23.9)	comparing	to	the	text-mining	positive	cohort	(M	=	7.4,	SD=	12,	P	=	0.022.)	
	Figure	3.2	Positive	opioid	use	problems	rate	stratified	by	age	group	
 Variables	of	Interest	In	this	study,	we	conducted	a	bi-variate	analysis	to	compare	positive	text-mining	cohorts	 vs.	 negative	 cohort.	 Chi-square	 and	 likelihood	 ratio	 were	 reported	 for	categorical	 variables	 (Table	 3.5)	 and	 an	 independent	 t-test	 were	 reported	 for	
	44	
continuous	variables	(Table	3.6).	The	following	variables	were	significant	on	alpha=	0.05	 and	 were	 ranked	 based	 on	 likelihood	 ratio	 and	 approximate	 change	 in	probability:	Non-opioid	Abuse,	Gender,	Tobacco	Use,	Self-Injury,	Depression,	Alcohol,	Abuse,	and	Hepatitis	C.	The	t-test	was	also	significant	on	the	 following	continuous	variables:	 age,	 outpatient	 visits,	 emergency	 department	 visits,	 hospitalizations,	cumulative	hospitalization	days.	Table	3.5	Measure	of	association	and	likelihood	ratio	for	categorical	variables	
Variable	 X2	 p-value	
Likelihood	
ratio	 p-value	
Approximate	
change	in	
probability	Non-opioid	Abuse	 55.457	 <	0.001	 20.083	 <	0.001	 >45%	Gender	 11.23	 0.001	 10.849	 0.001	 >45%	Tobacco	Use	 10.881	 0.001	 8.41	 0.004	 >40%	Self-Injury	 30.971	 <	0.001	 7.947	 0.005	 >35%	Depression	 6.186	 0.013	 4.994	 0.025	 >25%	Alcohol	Abuse	 6.616	 0.01	 3.823	 0.051	 >20%	Hepatits	C	 5.895	 0.015	 3.517	 0.061	 >20%		Table	3.6	Comparison	of	continuous	variables	among	positive	OUP	using	text	mining	vs.	negative	cohorts	
Variable	
Text-mining	
positive	 Mean	
Std.	
Deviation	 p-value	Age	 Yes	 44.98	 13.24	 <	0.001		 No	 59.02	 16.34	 	Outpatient	Visits	 Yes	 12.86	 12.4	 0.001		 No	 9.15	 10.48	 	Emergency	Department	visits	 Yes	 3.17	 4.91	 <	0.001	No	 0.94	 1.86	 	Hospitalizations	 Yes	 1.55	 2.57	 <	0.001		 No	 0.54	 1.138	 	Cumulative	Hospitalization	Days	 Yes	 7.42	 12.01	 <	0.001	No	 3.21	 17	 	
 Discussion	We	 identified	 23,082	 patients	who	 received	 LTOT	 during	 the	 study	 period,	 of	which	 14,298	 have	 eligible	 text	 mining	 of	 relevant	 electronic	 clinical	 notes	 that	yielded	127	positive	OUP	cases,	compared	to	45	cases	using	ICD-9	codes	for	the	same	population.	Our	study	methodology	followed	the	footsteps	of	previous	work	of	Carrell	
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et	al.	(2015),	Palmar	et	al.	(2015),	and	Hylan	et	al.	(2015)	[61,90,91].	This	offers	a	unique	opportunity	to	compare	population	characteristics	and	text	mining	results	to	identify	 opioid	 use	 problems	 in	 multi-healthcare	 settings.	 Below,	 we	 highlight	takeaway	findings	of	our	study.	
 Identification	of	Opioid	Use	Problems	We	measured	the	prevalence	of	opioid	use	problems	in	IUH	adult	patients	using	text	mining	and	ICD-9	codes.	In	our	study,	validated-text	mining	identified	127	(0.8%)	positive	 OUP	 cases	 out	 of	 14,298	 patients,	 while	 ICD-9	 had	 identified	 45	 (0.3%)	positive	OUP	cases	from	the	same	population	(Total	combined	=	164	[1.1%]).	Carrell	et	 al.	 (2015)–validated	 NLP	 have	 identified	 1,875	 (8.5%)	 patients	 out	 of	 21,795	patients	 eligible	 for	 the	 study,	while	 ICD-9	had	 identified	 2,240	 (10.1%)	 from	 the	same	 population.	 We	 believe	 the	 difference	 of	 opioid	 use	 problem	 prevalence	between	the	2	studies	could	be	due	to	several	factors	such	as	the	difference	between	opioid	 problem	 rates	 in	 both	 populations	 or	 the	 study	 design.	 In	 our	 study,	 we	included	5	different	reports	types	that	covers	emergency	department	and	primary	care	visits,	however,	our	study,	as	the	opposite	from	Carrell’s,	did	not	have	access	to	behavioral\mental	health	reports	due	to	42	CFR	part	2	-	confidentiality	of	substance	use	disorder	patient	records	[97].	These	reports	could	potentially	include	opioid	use	problem	related	data	and	adding	them	to	our	analysis	could	decrease	the	prevalence	disparities	between	the	2	studies.	Despite	the	differences	between	the	2	combined	percentages,	both	findings	 fall	within	 the	 estimated	 range	 reported	 in	 the	 literature.	 According	 to	 Ballantyne’s	commentary	published	in	the	journal	journal	PAIN	in	2015,	published	estimates	of	
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opioid	use	problems	ranged	from	<	1%	to	50%	[98].	Our	findings	are	consistent	with	other	studies	estimating	opioid	problems	in	the	context	of	long-term	opioid	therapy.	Noble	et	al.	 (2010)	conducted	a	study	to	assess	safety,	efcacy,	and	effectiveness	of	opioids	 taken	 long-term	 for	 chronic	 non-cancer	 patients.	 The	 study	 reviewed	 26	articles	and	included	only	patients	who	had	at	 least	6	months	of	opioid	treatment.	According	to	the	study,	signs	of	opioid	addiction	were	reported	in	only	0.27%	of	4,893	study	participants	[99].	
 Frequency	of	ICD	Criteria	to	Identify	OUP	Our	study	used	a	broad-spectrum	definition	of	opioid	use	problems	comprised	of	2	sets	of	ICD-9	codes	for	opioid	abuse	and	dependence-as	well	as	opioid	poisoning.	This	 is	 different	 from	 Carrell’s	 study	 which	 only	 included	 those	 for	 opioid	 abuse	(305.5,	 305.51,	 or	 305.52),	 and	 opioid	 dependence	 (304,	 304.01,	 304.02,	 304.7,	304.71,	or	304.72).	Our	inclusion	of	opioid	poising	codes	has	detected	an	additional	8	distinct	patients.	This	equals	17%	of	 the	overall	positive	OUP	detected	by	 ICD-9	codes	in	our	study.	Overall,	our	study	population	generated	49	ICD-9	events,	representing	45	distinct	patients.	 The	 most	 commonly	 used	 ICD-9	 codes	 were	 304	 [opioid	 dependence	unspecified]	 (49%),	 305.5	 [opioid	 abuse	 unspecified]	 (18%),	 and	 304.1	 [opioid	dependence	continuous]	(10%).	These	findings	are	similar	to	the	results	reported	by	Palmer	et	al.	(2015).	The	study	investigated	the	prevalence	of	opioid	problems	among	chronic	opioid	therapy	patients	in	the	Group	Health	Cooperative	from	2006	to	2012.	The	most	commonly	reported	ICD-9	codes	were	304	[opioid	dependence	unspecified]	(55%),	 304.1	 [opioid	 dependence	 continuous]	 (26%),	 and	 305.5	 [opioid	 abuse	
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unspecified]	 (10%)	 [100].	 Similar	 to	 the	 common	use	 of	 unspecified	 ICD	 codes	 to	identify	OUP,	a	pattern	was	noticed	by	our	reviewers	during	a	manual	review	process	of	patients’	clinical	notes.	In	this	study,	we	found	unspecified	criteria	[Physician	states	opioid	abuse/overuse/addiction	or	 listed	ICD	codes	 for	opioid	abuse/dependence]	represented	38%	of	positive	OUP	in	the	text	mining	approach.	These	findings	suggest	a	 common	 pattern	 in	 OUP	 identification	 between	 ICD-9	 codes	 and	 a	 text-mining	approach.	
 Frequency	of	Text-Mining	Criteria	to	Identify	OUP	In	our	study,	we	have	used	17	criteria	to	identify	OUP	from	clinical	notes.	The	main	difference	 in	 these	 criteria	 compared	 to	 Carrells’	 are	 the	 following:	 1-	 we	 have	included	marijuana	as	part	of	our	list	of	illicit	drugs	2-	We	added	concurrent	use	of	authorized	narcotics	to	include	specific	cases	of	polypharmacy	of	narcotic	abuse.	We	added	 a	 criteria	 to	 cover	 cases	 where	 physician	 states	 narcotic	 abuse,	 overuse,	addiction	or	listed	ICD	codes	for	opioid	abuse/dependence.	In	our	study,	use	of	an	illicit	drug	criteria	comprised	of	18	cases,	of	which	3	cases	indicated	active	marijuana	use	 (within	 the	 last	 month)	 without	 mentioning	 other	 illicit	 drug	 abuse.	Polypharmacy	 of	 narcotic	 abuse	 flagged	 another	 11	 OUP	 cases.	 The	 third	 criteria	yielded	48	positive	OUP	cases,	of	which,	16	cases	have	one	or	more	mentions	of	ICD-9	code	diagnosis	of	abuse	and	dependence	within	the	clinical	notes.	Out	of	those	16	patients,	there	was	only	one	patient	who	had	a	documented	ICD-9	for	opioid	abuse	and	dependence	in	the	structured	data.	
	
	 	
	48	
Demographics	In	this	study,	we	found	women	were	represented	more	than	men,	overall.	This	is	consistent	with	Carrell	et	al.	(2015)	and	Hylan	et	al.	(2015)	which,	both	have	found	women	 to	 represent	about	 two-thirds	of	 the	 chronic	opioid	 therapy	population	 in	their	studies.	Overall,	higher	women’s	representation	is	consistent	with	the	national	estimates	of	opioid	prescriptions	per	gender.	According	to	the	national	statistics	by	the	 CDC,	 there	 were	 58%	 women	 vs.	 42	 %	 men	 who	 filled	 at	 least	 one	 opioid	prescription	 in	2014[95].	However,	despite	more	women	than	men	seeking	opioid	prescriptions	in	the	U.S.,	men	had	higher	rates	of	opioid-related	disorders,	such	as	opioid	 abuse	 or	 opioid	 overdose.	 In	 2016,	 the	 opioid	 overdose	 deaths	 by	 gender	showed	men	had	18.1	deaths	per	100,000	vs.	8.5	for	women	in	the	U.S.and	16.7	vs.	8.5,	respectively,	 in	Indiana	[96].	Our	study	results	are	consistent	with	this	notion;	while	positive	OUP	distribution	stratified	by	gender	showed	a	higher	rate	of	women	with	OUP,	the	rate	of	overall	positive	OUP	indicates	a	higher	rate	of	positive	OUP	for	men.	Mirroring	nationwide	trends	of	opioid	prescription	by	age,	age	distribution	of	the	overall	study	cohort	was	skewed	toward	an	older	age	(>	65),	which	was	the	highest	representation	in	the	study	cohort	[97].	Frequency	of	positive	OUP	distribution	was	the	highest	in	the	group	age	45-54	in	both	the	ICD	and	text-mining	methods.	However,	the	rate	of	positive	OUP	per	group	age	indicates	younger	age	groups	had	the	highest	OUP	 rate	 among	 age	 groups	 in	 ICD	 and	 text-mining	 cohorts.	 This	 should	 inform	physicians	in	Indiana	that	despite	the	higher	frequency	of	older	patients	with	opioid	
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problems	that	they	might	encounter,	younger-age	patients	are	the	ones	at	higher	risk	for	an	opioid	problem.	
A	Note	About	Opioid	Problem	Detection	Using	Structured	Data	Despite	 the	 study	which	used	a	 combination	of	2	 types	of	 ICD-9	 codes	 (opioid	abuse	and	dependence	and	poisoning),	overall,	our	text-mining	approach	identified	more	cases.	The	text-mining	approach	also	detected	15	patients	with	a	mention	of	an	ICD-9	code	of	opioid	abuse	and	dependence	in	patients’	clinical	notes,	but	these	codes	were	 undocumented	 in	 patients’	 record	 as	 structured	 data.	 This	might	 indicate	 a	significant	lack	of	documentation	toward	opioid	use	problems	and	confirm	previous	studies’	 findings	 regarding	 the	 under-reporting	 of	 OUP	 using	 ICD-9.	 For	 future	research	pertaining	to	identifying	OUP,	we	recommend	using	alternate	methods	(in	 addition	 to	 ICD	 codes),	 such	 as	 text	mining	 and	machine	 learning,	 and	 further	exploring	other	 commonly	documented	structured	data,	 such	as	procedural	 codes	and	electronic	lab	results.	
 Limitations	In	this	study,	we	used	a	text-mining	approach	to	analyze	patients’	clinical	notes	to	identify	OUP.	However,	 the	analysis	was	 limited	to	5	report	 types.	Developing	and	implementing	NLP	techniques	generally	requires	intensive	computing	and	an	initial	commitment	of	substantial	resources	and	expertise	[101].	Thus,	it	was	not	financially	feasible	within	the	allocated	budget	for	this	study	to	test	all	report	types	generated	by	 the	 IUH	 study	 population.	 Rather,	 the	 authors	 relied	 on	 expert	 opinions	 to	meaningfully	 limit	 the	number	 of	 report	 types.	Reliance	 on	 expert	 opinion	during	algorithm	development	is	common	in	opioid	problem	identification	literature.	Canan	
	50	
et	al.	 (2017)	reviewed	15	automated	algorithms	to	 identify	nonmedical	opioid	use	using	 electronic	 health	 record	 data.	 The	 study	 found	 that	 investigators	 explicitly	relied	on	subject	matter	experts	during	the	process	of	algorithm	development	and	to	identify	candidate	variables	[101].	Another	limitation	pertaining	to	study	results	is	that,	despite	text	mining	correctly	identifying	 127	 positive	 cases	 out	 of	 154	 initial	 positive	 cases	 (PPV	 =	 82%),	 the	overlap	between	the	text-mining	results	and	ICD-9	positive	results	was	only	8	cases	(17%)	 (Appendix	A.1).	 This	may	 suggest	 that	 the	 text	mining	method	 has	missed	some	 positive	 cases	 (false	 negative).	 To	 investigate	 this	 assumption,	 we	 have	reviewed	500	randomly	selected	reports	 that	were	not	 flagged	by	our	 text-mining	criteria.	Among	the	500	reports,	we	 identified	10	 false	negative	cases,	 indicating	a	negative	predictive	value	of	98%	on	the	reviewed	subset.	Finally,	 we	 used	 multiple	 behavioral	 concepts	 to	 define	 opioid	 use	 problems	(dependence,	 abuse,	 and	 addiction)	 and	 thus,	 distinguishing	 specific	 behavioral	concepts	was	not	automated	in	this	research.	Future	work	may	investigate	using	text	mining,	natural	language	processing,	and	machine	learning	to	better	target	specific	behaviors.	
 Conclusion	In	this	study,	we	developed	a	text-mining	approach	to	identify	OUP	among	long-term	 opioid	 therapy	 patients	 at	 IUH.	 Compared	 to	 ICD-9	 codes,	 text	 mining	successfully	 identified	 more	 OUP	 cases	 within	 the	 study	 population.	 Future	development	 of	 text-mining	 techniques	 can	 help	 identify	 cases	 undiscovered	 by	conventional	ICD-9	reporting	methods.	 	
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4. MACHINE-LEARNING	APPROACH	TO	IDENTIFY	OPIOID	USE	PROBLEMS	
 Introduction	In	2012,	opioid	prescriptions	reached	their	peak	with	81.3	prescriptions	per	100	people	[98].	Despite	more	recent	reports	showing	that	this	number	has	decreased	to	66.5	prescriptions	per	100	people,	 the	opioid	prescription	rate	 in	2015	remains	3	times	higher	than	the	rates	from	1999	[99],	and	more	than	a	quarter	of	U.S.	counties	are	still	showing	dispensed	opioid	prescription	numbers	equivalent	to	or	higher	than	their	populations	[98].	The	disparities	over	prescribing	opioids	across	the	nation	has	continued	throughout	the	years.	In	fact,	in	2016,	some	counties	had	prescription	rates	7	times	higher	than	the	nation’s	average	[98–100].	The	link	between	average	daily	opioid	prescription	and	opioid	overdose	has	been	established	[101].	According	to	Dunn	et	al.	(2010),	long-term	opioid	therapy	patients	receiving	higher	doses	of	opioids	are	at	a	higher	risk	of	drug	overdose	[102].	Other	studies	 have	 found	 an	 association	 between	 heroin	 use	 and	 an	 increased	 rate	 of	nonmedical	opioid	use	and	meet	the	criteria	for	opioid	abuse	[103].	Despite	the	importance	of	the	opioid	abuse	issue,	the	current	healthcare	system	mainly	 relies	 on	 the	 International	 Classification	 of	 Disease	 (ICD)	 to	 report	 use	problems,	which	underestimates	the	actual	number	of	patients	exhibiting	the	target	categorization	[57,58].	In	recent	years,	several	studies	have	been	conducted	to	investigate	the	validity	of	other	methods,	 such	 as	 natural	 language	 processing	 and	 text	mining,	 to	measure	opioid	problems,	 in	addition	 to	 ICD	codes.	However,	 to	our	knowledge,	no	studies	have	been	conducted	to	measure	the	presence	of	opioid	problems	among	long-term	
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opioid	users	via	machine-learning	techniques.	The	aim	of	this	chapter	is	to	investigate	the	application	of	machine-learning	techniques	to	classify	opioid	use	problems	(OUP)	utilizing	 patients	 clinical	 notes.	 For	 this	 study,	 we	 define	 OUP	 as	 the	 presence	 of	opioid	aberrant	behaviors,	opioid	misuse,	opioid	abuse	and	opioid	use	disorder	in	the	patient’	clinical	notes.	
 Method	
 Machine-Learning	Process	Summary	To	prepare	for	machine-learning	process,	2	reviewers	had	reviewed	700	clinical	notes	using	nDepth™	to	determine	opioid	use	problem	cases.	Report	contents,	along	with	 review	 results,	 were	 extracted	 by	 the	 Regenstrief	 Institute	 data	 core	 into	comma-separated	values	(CSV)	files	and	Portable	document	format	(PDF)	files.	The	review	of	700	clinical	notes	resulted	in	145	positive	reports	for	opioid	use	problems	(OUP)	 and	 555	 negative	 reports	with	 no	 indication	 of	 OUP	 in	 the	 text.	 To	 ensure	HIPAA	compliance,	the	files	were	stored	and	processed	on	the	Karst	desktop,	an	IU	remote	secure	supercomputer	(Figure	4.2).	To	prepare	data	for	machine	 learning,	2	Java	programs	were	written	to	extract	text	 from	 each	 of	 the	 PDF	 and	 CSV	 clinical	 notes	 files	 and	 they	 were	 saved	 into	separate	 TXT	 files.	 For	 the	 machine-learning	 process,	 Waikato	 Environment	 for	Knowledge	 Analysis	 (WEKA)	 was	 used	 to	 build	 and	 compare	 machine-learning	models	on	a	document	level.	Performance	was	compared	based	on	F-measure,	recall,	and	precision	for	5	models.	The	best	model	performance	was	optimized	and	finalized	into	 a	 standalone	 product	 to	 identify	 the	 OUP	 outcome	 among	 long-term	 opioid	
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therapy	patients	at	IUH	based	on	their	medical	records.	Finally,	the	model	was	tested	on	a	subset	of	unseen	data,	and	the	model	reported	the	results	(Figure	4.2).	
Gold	Standard	Development	(nDepth™)	To	create	a	gold	standard	for	the	machine-learning	process,	2	trained	reviewers	manually	reviewed	700	reports	with	a	semi-assisted	manual	review	process	using	nDepth™.	The	Regenstrief	 Institute	 in	 Indianapolis	designed	nDepth™	as	a	natural	language	processing	tool	with	which	to	extract	data	 from	the	 Indiana	Network	 for	Patient	 Care	 (INPC).	 Furthermore,	 nDepth™	 was	 programmed	 to	 highlight	 27	suggestive	words	 in	 flagged	 reports	 (Table	 A.2).	When	more	 than	 one	 report	 per	patient	was	flagged,	the	system	randomly	selected	one	type	of	the	flagged	reports	per	patient	to	be	reviewed.	To	establish	the	Kappa	coefficient,	both	reviewers	reviewed	200	 identical	 reports.	 In	 case	 of	 the	 discrepancy,	 files	 were	 reevaluated	 and	consensus	 was	 reached.	 Cohen’s	 κ	was	 run	 to	 determine	 if	 there	 was	 agreement	between	the	2	reviewers	judgment	regarding	whether	a	subset	of	200	patients	in	the	study	cohort	met	any	OUP	criteria.	There	was	moderate	agreement	between	the	2	reviewers	 judgments:	κ	=	0.691	 (95%	CI,	 0.58	 to	0.79),	p	<	 .001.	Our	overall	 gold	standard	dataset	consisted	of	136	positive	OUP	reports	and	480	negative	reports.	The	criteria	to	determine	opioid	use	problems	in	clinical	notes	are	listed	in	Table	3.1.	
Data	Transformation	(Java)	The	700	manually	reviewed	clinical	notes,	which	consisted	of	132	PDF	and	568	CSV	reports,	were	uploaded	into	Karst.	Karst	Desktop	is	a	remote	desktop	service	for	users	 with	 accounts	 on	 the	 Karst	 research	 supercomputer	 [92].	 As	 part	 of	 the	machinelearning	 processes,	 text	 from	 both	 CSV	 and	 PDF	 reports	 needed	 to	 be	
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transformed	 into	 TXT	 files	 for	 each	 report.	 Thus,	 a	 Java	 program	was	 written	 to	extract	data	from	the	PDF	and	CSV	files	(Appendix	D.1	and	Appendix	D.	2).	A	sample	of	the	extracted	data	was	reviewed	to	validate	the	extraction	process	to	confirm	data	correctness	and	completion.	As	a	final	step	to	prepare	the	data	for	WEKA,	text	was	converted	into	Attribute-Relation	File	Format	(ARFF).	ARFF	is	“an	ASCII	text	files	that	describes	a	list	of	instances	sharing	a	set	of	attributes.	ARFF	files	were	developed	by	the	machine-learning	project	at	the	department	of	computer	science	of	the	University	of	Waikato	for	use	with	the	WEKA”	[103].	
 Analysis	
 WEKA	Configuration	and	Model	Comparison	In	the	process	of	model	building,	training	the	model	on	a	larger	sample	size	usually	produces	higher	model	performance	compared	 to	 training	 the	model	on	a	smaller	sample	 size	 [104].	 However,	 the	 model-building	 process	 also	 considers	 class	representation	 balance	 in	 the	 training	 process,	 [105,106]	 which	 can	 lead	 to	 the	inability	to	classify	the	unbalanced	data	due	to	lack	of	prior	information	in	the	model	training	 [106,107].	 Class	 imbalance	 is	 characterized	 as	 there	 being	 “many	 more	instances	of	 some	classes	 than	others”	 [107,108].	The	 fundamental	 challenge	with	training	a	model	on	imbalanced	data	is	the	ability	of	imbalanced	data	to	“significantly	compromise	the	performance	of	the	most	standard	learning	algorithms”	[109].	In	 previous	 years,	 many	 solutions	 have	 been	 introduced	 to	 deal	 with	 the	imbalanced	data	problem	and	can	be	summarized	as	 follows:	1-	Data	sampling:	 in	which	 the	model	 is	 trained	 on	 a	more	 balanced	 distributed	 dataset	 [107,110];	 2-	Algorithmic	modification:	in	which	adopting	base-learning	algorithms	needs	“to	be	
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more	 attuned	 to	 class	 imbalanced”	 [107,111];	 3-	 Cost-sensitive	 learning:	 this	approach	 considers	modification	 on	 data	 level,	 algorithm	 level,	 or	 both,	 in	 which	considering	misclassification	of	one	data	class	(e.g.,	positive	class)	cost	is	higher	than	another	data	class	(e.g.,	negative	class)	 thus,	algorithm	performance	 is	adjusted	 to	minimize	the	higher	cost	error	(misclassify	positive	class)	[107,112].	Our	gold	standard	dataset	has	about	an	80%	negative	and	a	20%	positive	class	imbalance.	Balancing	the	data	in	the	WEKA	training	model	on	50/50	or	40/60	class	representation	 is	 recommended	 [113].	 However,	 adopting	 this	 approach	 might	jeopardize	 the	 real-world	 application	 of	 the	 model,	 given	 the	 difference	 in	 prior	probability	between	the	training	environment	and	real-world	application	[107,114].	Hence,	 for	 this	 chapter,	we	 decided	 to	 use	 an	 ensemble	 approach,	where	 first	we	explore	multiple	algorithms	and	various	classification	configurations	and	compare	their	 performance	 on	 a	 balanced	 subset	 of	 data	 that	 has	 similar	 representation	between	positive	and	negative	reports.	Second,	once	we	determine	the	best	WEKA	configuration	with	which	 to	 classify	 the	 2	 classes,	we	will	 optimize	 the	model	 by	introducing	560	(80%)	of	 the	gold	standard	reports	to	enhance	the	aspect	of	real-world	application	of	the	model	(because	real	world	data	is	not	balanced)	[111].	To	standardized	testing	environment,	cross-validation	(k	=	10)	will	be	used	across	all	of	the	models.	Finally,	the	optimized	model	will	be	tested	on	a	unseen	data	subset	consisting	of	140	 (20%)	 clinical	 notes.	 Our	 intention	 in	 the	 optimization	 step	 is	 to	 maximize	positive	 report	 detection	 (less	 false	 negatives),	while	maintaining	minimal	 loss	 of	precision.	 The	 rationale	 behind	 the	 ensemble	 approach	 is	 that	 classifiers	 are	
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commonly	designed	to	minimize	error	when	they	make	predictions	about	new	data.	However,	 this	 assumption	 is	 proper	 when	 the	 cost	 of	 different	 errors	 is	 equally	important	 [112,115].	 In	 this	 research,	we	 sought	 to	prioritize	 the	minimization	of	false	 negatives	 (by	 capturing	 more	 true	 positives,	 while	 risking	 an	 increase	 in	capturing	 false	 positives).	 Accuracy	 measures,	 such	 as	 F-measures,	 recalls,	 and	precision,	will	be	reported	for	each	step.	The	highlights	of	the	WEKA	configuration	(Table	4.1)	and	the	complete	model	schema	(Figure	4.1)	for	best	model	performance	will	 be	 reported.	 The	 complete	 model	 training	 steps	 of	 WEKA	 are	 reported	 in	Appendix	C.1	to	Appendix	C.19.	
	Figure	4.1	WEKA	model	configurations	Table	4.1	Highlight	of	WEKA	configurations	
Option	 Chosen	Features	 Comment	Classifier	 FilteredClassifer	 Cost-sensitive	classifier	was	added	to	optimize	the	final	model.	Algorithm	 1-Linear	Algorithm:	Simple	Logistic	2-Non-Linear	Algorithm:	SMO	/J48/NaiveBayes	3-Ensemble	Algorithm:	RandomForest	
For	Simple	Logistic:	batch	size:100,	heuristic	stop:	50,	max	boosting	iteration:	500,	number	of	boosting	iteration:	0	number	of	decimal	places:	2	Filter	 StringToWordVector:	 IDFTransform:	True,	TFTransform:	True,	LowerCaseToken:	True.	Words	to	keep:	1000	StopWordsHandler	 MultiStopWords	 	Tokenizer	 NGramTokenizer	 Max	3,	Min	1	
 Model	Finalization	The	model	with	best	accuracy	measure	performance	will	be	saved	as	standalone	MODEL	 files.	 The	 MODEL	 extension	 is	 a	 common	 files	 type	 for	 digital	 product	
“Scheme:	weka.classifiers.meta.FilteredClassifier	-F	&quot;weka.filters.unsupervised.attribute.StringToWordVector	-R	first-last	-W	1000	-prune-	rate	-1.0	-T	-I	-N	0	-L	-stemmer	weka.core.stemmers.IteratedLovinsStemmer	-	stopwords-handler	weka.core.stopwords.MultiStopwords	-M	1	-tokenizer	\&quot;weka.core.tokenizers.NGramTokenizer	-max	3	-min	1	-delimiters	\\\&quot;	\\\\r\\\\n\\\\t.,;:\\\\\\\&#39;\\\\\\\&quot;()?!\\\&quot;\&quot;&quot;	-S	1	-W	weka.classifiers.functions.SimpleLogistic	--	-I	0	-M	500	-H	50	-W	0.0”	
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definitions	and	simulations	[116].	The	files	can	be	loaded	by	WEKA	onto	any	PC	or	Mackintosh	environment	and	used	to	classify	cases	of	opioid	use	problems	in	unseen	reports	from	IUH.	
 Results	
 Model	Comparison	We	 used	WEKA	 to	 build	 and	 test	 files	 among	 different	models	 to	 classify	 IUH	clinical	notes	into	positive	and	negative	for	opioid	use	problems	using	a	balancedclass	dataset.	 The	 training	 set	 consisted	 of	 136	 positive	 reports	 and	 similar	 negative	reports,	which	were	uploaded	 to	WEKA.	The	 following	 algorithms	were	used:	 J48	(default	WEKA	algorithm),	simple	logistic,	naive	bayes,	random	forest,	and	sequential	minimal	 optimization	 (SMO).	 All	 models	 were	 tested	 based	 on	 a	 10-fold	crossvalidation.	 Our	 model	 comparison	 has	 shown	 the	 Simple	 Logistic	 algorithm	showed	 better	 performance	 than	 other	 models	 for	 predicting	 positive	 class	(Precision:	 91.9%;	 Recall:	 91.2%;	 F-measure:	 91.5%;	 ROC:	 92%)	 (Table	 4.2).	 The	detailed	accuracy	measure	performances	for	simple	logistic	are	listed	in	Table	4.3.	
 Model	Optimization	To	enhance	model	real-world	application,	simple	logistic	model	configuration	was	optimized	on	80%	of	the	gold	standard	dataset,	which	was	comprised	of	560	reports	(136	positive	and	424	negative).	Compared	 to	 the	balance	dataset,	 the	model	had	initially	 underperformed	 when	 larger	 portions	 of	 the	 negative	 dataset	 were	introduced	(Table	4.4).	The	model	has	classified	37	(27%)	out	136	positive	cases	as	false	negative	cases.	
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Table	4.2	Comparison	of	multiple	models’	performances	to	identify	positive	OUP	
Accuracy	measures	to	classify	positive	reports	
Algorithm	 Precision	 Recall	 F-Measure	Simple	Logistic	 0.919	 0.912	 0.915	J48	 0.847	 0.853	 0.85	RandomForest	 0.756	 0.934	 0.836	SMO	 0.797	 0.838	 0.817	NaiveBayes	 0.821	 0.64	 0.719		Table	4.3	Detailed	accuracy	performance	measure	for	simple	logistic	algorithm	to	classify	OUP	
Class	 TP	Rate	 FP	Rate	 Precision	 Recall	 F-	Measure	 ROC	Area	Positive	 0.921	 0.079	 0.919	 0.912	 0.915	 0.931	Negative	 0.921	 0.088	 0.915	 0.921	 0.918	 	Weighted	Avg.	 0.917	 0.083	 0.917	 0.917	 0.917	 		Table	4.4	Initial	simple	logistic	model	performance	on	80%	of	the	gold	standard	data		Class	 TP	Rate	 FP	Rate	 Precision	 Recall	 F-	Measure	 ROC	Area	Positive	 0.728	 0.052	 0.818	 0.728	 0.77	 0.94	Negative	 0.948	 0.272	 0.916	 0.948	 0.932	 	Weighted	Avg.	 0.895	 0.219	 0.892	 0.895	 0.892	 		Table	4.5	Optimized	simple	logistic	model	performance	on	80%	of	the	gold	standard	data	
Class	 TP	Rate	 FP	Rate	 Precision	 Recall	 F-	Measure	 ROC	Area	Positive	 0.897	 0.094	 0.753	 0.897	 0.819	 0.890	Negative	 0.906	 0.10	3	 0.965	 0.906	 0.934	 	Weighted	Avg.	 0.904	 0.101	 0.913	 0.904	 0.906	 	
	Table	4.6	Simple	logistic	confusion	matrix	comparison	before	and	after	optimization	
Confusion	Matrix	(N=560:	136	Positive,	424	Negative)	
Before	optimization	 After	Optimization	
Negative	 Positive	 Negative	 Positive	402	 22	 384	 40	37	 99	 14	 122	
	Table	4.7	Simple	logistic	model	performance	tested	on	20%	of	unseen	gold	standard	data	
Class	 TP	Rate	 FP	Rate	 Precision	 Recall	 F-	Measure	 ROC	Area	Positive	 0.889	 0.030	 0.667	 0.889	 0.762	 0.924	Negative	 0.970	 0.111	 0.992	 0.970	 0.981	 	Weighted	Avg.	 0.965	 0.106	 0.971	 0.965	 0.967	 		
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	Figure	4.2	Summary	of	chapter	4	method	and	results	To	 account	 for	 this	 effect,	 a	 cost-sensitive	 classifying	 technique	 was	 adopted.	Costsensitive	 classifying	 is	 one	 method	 to	 fine-tune	 model	 performance	 through	increasing	the	penalty	of	misclassifying	one	or	more	classes	in	the	confusion	matrix	
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(Appendix	C.20	to	Appendix	C.28).	Adjusting	the	model	cost	sensitively	matrix	to	2:1	has	 doubled	 the	 penalty	 of	 misclassifying	 positive	 cases	 as	 false	 positives,	 which	resulted	in	a	decrease	in	false	positive	cases	(Table	4.5),	dropping	the	total	to	only	14	(10%)	cases	out	of	136.	A	complete	confusion	matrix	for	both	models’	outcomes	is	listed	in	Table	4.6.	
 Model	Testing	The	finalized	model	was	tested	on	140	reports	(20%	of	our	gold	standard	data).	These	data	were	not	used	initially	in	the	process	of	training	and	testing	the	model.	On	the	unseen	data,	the	model	has	correctly	classified	136	(96.4%)	reports	with	88.9%	 sensitivity	 to	 identify	 positive	 cases.	 The	 accuracy	 measures	 to	 classify	positive.	reports	were	the	following:	Precision:	0.667,	Recall:	0.889,	and	F-Measure:	0.762.	The	complete	performance	measures	are	listed	in	Table	4.7	
 Discussion	In	this	chapter,	we	built	a	machine-learning	model	to	identify	opioid	use	problems	based	on	Indiana	University	Health	clinical	notes.	The	positive	and	negative	reports,	which	 had	 been	 extracted	 and	manually	 reviewed	 using	 nDepth™	 in	 the	 previous	chapter,	were	pre-processed	and	uploaded	into	WEKA,	which	was	used	to	create	a	model	to	identify	opioid	use	problems.	In	this	section,	we	highlight	some	of	the	key	points	of	this	work.	
 Algorithms’	Performance	We	tested	5	different	algorithms	to	classify	opioid	use	problems	on	a	document	level	 (Appendix	 B.1	 to	 Appendix	 B.5).	 simple	 logistic	 regression	 showed	 overall	higher	accuracy	performance	measures	 in	classifying	positive	opioid	use	problems	
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on	 a	 balanced	 dataset	 (Table	 4.2).	 We	 found	 this	 interesting,	 given	 the	 growing	number	 of	 published	 articles	 discussing	 the	 superiority	 of	 random	 forest	 and/or	support	 vector	 machines	 over	 logistic	 regressions	 [117,118].	 However,	 a	 recent	article	 by	 Pranckeviˇcius	 et	 al.	 (2017)	 compared	 Naive	 Bayes,	 Random	 Forest,	Decision	Tree,	Support	Vector	Machine	and	logistic	regression	classifiers	to	classify	text	reviews	(multi-class	textual	data).	The	study	found	that	logistic	regression	has	achieved	 the	highest	classification	accuracy	compared	with	other	classifiers	 [119].	This	 can	 be	 explained	 by	 the	 signal-to-noise	 ratio.	 One	 opinion	 article	 we	 found	discussed	the	advantages	of	logistic	regressions	over	tree	decision	models;	the	article	found	that	 logistic	regressions	perform	better	when	the	signal-tonoise	ratio	 is	 low	[120].	Given	the	large	text	data	(noise)	compared	to	the	signal	(phrases	or	statements	indicating	an	opioid	use	problems),	we	decided	to	investigate	this	hypothesis	and	see	if	 logistic	 regression	 will	 still	 perform	 better	 if	 we	 limit	 our	 model	 training	 to	sentences	and	phrases.	Thus,	we	have	manually	reviewed	all	of	the	positive	reports	and	300	of	the	negative	reports	to	annotate	statements	and	phrases	that	indicate	or	negate	the	presence	of	opioid	use	problems	using	the	Extensible	Human	Oracle	Suite	of	Tools	(eHOST).	This	process	has	resulted	in	255	sentences	and	phrases	indicating	the	presence	of	an	opioid	use	problems.	However,	it	only	yielded	55	sentences	and	phrases,	negating	the	presence	of	an	opioid	use	problems.	Finally,	we	applied	similar	settings	 to	 compare	 the	 following	 4	 classifiers:	 logistic	 regression,	 random	 forest,	Naive	Bayes	and	SMO.	Our	results	showed	that	random	forest	and	SMO	scored	slightly	higher	than	logistic	regression	and	Naive	Bayes	(Appendix	B.6).	
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 Cost-Sensitive	Classifier	In	this	study,	we	found	that	cost-sensitive	classifier	is	an	effective	method	to	use	to	 adjust	 for	 the	 data	 imbalance.	 Adjusting	 the	 cost	 matrix	 has	 increased	 recall	performance	while	lowering	the	precision	of	predicting	positive	cases	in	the	model	by	increasing	(doubling)	the	penalty	for	making	a	false	negative	error.	Our	rationale	for	this	approach	arises	from	the	intention	to	minimize	missing	true-positive	cases.	We	believe	that	identifying	more	positive	OUP	cases	will	allow	future	researchers	to	better	 understand	 why	 this	 sector	 of	 positive	 OUP	 patients	 (according	 to	 their	reports)	was	not	documented	using	ICD	as	an	opioid	use	problems	case.	Furthermore,	due	to	the	importance	of	opioid	issues	from	a	clinical	perspective,	and	given	the	small	representation	of	opioid	use	problems	cases	in	the	IUH	system	(about	1%),	building	a	high-sensitivity	model	to	detect	positive	OUP	in	long-term	opioid	therapy	patients	based	 on	 their	 clinical	 notes	may	 seem	 like	 a	 practical	 approach,	 given	 the	 small	percentage	 of	 positive	 OUP	 cases.	 Such	 a	 pragmatic	 approach	 might	 not	 be	uncommon	 in	 screening	 tests;	mammograms	are	 a	 common	example	of	 screening	tests	where	sensitivity	is	higher	than	specificity	[121,122].	
 Limitation	Our	gold	standard	data	were	determined	by	manually	reviewing	the	text-mining	algorithm	to	identify	opioid	use	problems.	Any	positive	report	subclass	that	was	not	captured	 by	 the	 text-mining	 algorithm	may	 not	 be	 represented	 in	 our	model.	 To	account	for	this	limitation,	we	have	intentionally	added	all	false	positive	reports	as	part	of	our	training	model	and	labeled	them	as	negative	reports.	Furthermore,	500	
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random	negative	reports	(from	the	text-mining	algorithm)	were	manually	reviewed,	and	false	negative	reports	were	added	to	the	training	set	as	positive	cases.	
 Conclusion	In	this	chapter,	we	adopted	an	ensemble	approach	to	build	a	machine-learning	model	 to	 identify	opioid	use	problems	based	on	 Indiana	University	Health	 clinical	notes.	Our	final	model	was	tested	on	unseen	data	and	reported	a	sensitivity	of	88%	when	identifying	positive	cases.	We	concluded	that	a	machine-learning	approach	may	be	used	to	identify	opioid	use	problems	in	Indiana.		 	
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5. SUMMARY	
 Summary	Overview	In	 this	 thesis,	 we	 aimed	 to	 build	 a	 classification	 model	 to	 identify	 opioid	 use	problems	 using	 text-mining	 and	 machine-learning	 approaches.	 Additionally,	 we	examined	 several	 opioid	 use	 problems	 classification	 tools/models	 and	 identified	their	strengths	and	weaknesses.	Generally,	these	tools	can	be	categorized	into	three	classes,	 depending	 on	 the	 data	 population	method	 as	 follows:	 1-	 Self-report	 tools	(First	generation),	2-	Structured	data	models	(Second	generation),	3-	Clinical	notes	models	(Third	generation).	Below	we	synthesize	the	findings	of	this	thesis	in	light	of	this	classification.	
 Self-report	Tools	(First	Generation)	These	are	risk-assessment	tools	that	predict	the	risk	of	current	or	future	opioid	use	problems	based	on	predictive	variables	extracted	from	data	self-reported	by	the	patient	 or	 physician.	 Common	 examples	 of	 self-report	 tools	 are	 SOAPP,	 ORT,	 and	COMM.	 The	main	 advantage	 of	 these	 tools	 is	 their	 independence	 from	 electronic	health	record	data	and	can	be	administered	to	the	patient	or	filled	out	by	the	treating	physician.	 However,	 having	 the	 majority	 of	 these	 tools	 solely	 rely	 on	 patient	completion	might	have	limited	their	ability	to	predict	aberrant	drug-taking	behavior	due	to	reporting	bias	or	a	 lack	of	patient	comprehension.	Other	 factors	 that	might	hinder	using	self-report	tools	are	the	need	for	documentation	from	the	medical	staff	and	 the	 large	variation	 in	 its	 sensitivity	 across	different	populations	and	different	outcome	definitions.	
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 Structured	Data	Models	(Second	Generation)	These	are	risk-assessment	models	that	predict	the	risk	of	current	or	future	opioid	use	 problems	 based	 on	 predictive	 variables	 extracted	 from	 structured	 data	 of	electronic	health	records.	Common	examples	of	these	models	are	the	work	of	Edlund	et	al.	(2007),	White	et	al.	(2009),	Rice	et	al.	(2012),	Turner	et	al.	(2014),	and	others.	These	models	do	not	rely	on	patient	reported	data	(directly),	rather,	it	depends	on	the	 structured	 data	 available	 in	 the	 electronic	 health	 records.	 However,	 this	dependence	on	electronic	health	records	structured	data	makes	these	models	as	good	as	the	quality	and	robust	nature	of	captured	data	stored	in	the	electronic	record.	For	example,	the	number	of	prescribers	and	the	number	of	dispensers	have	been	shown	to	be	a	risk	indicator	for	opioid	use	problems.	However,	including	these	data	into	a	classifying	or	predictive	model	may	require	pre-work	to	consolidate	these	data	from	multiple	 databases	 (such	 as	 Prescription	 Monitoring	 Programs).	 Thus,	 it	 was	 no	surprise	to	see	Age	and	Gender	as	the	only	common	variables	across	the	9	models	we	found	 using	 structured	 data.	 However,	 with	 the	 constant	 growth	 of	 the	 Health	Information	Exchange	in	size	and	number,	we	expect	to	see	more	robust	models	in	the	 future	 that	 identify	 and	 utilize	 new	 variables	 to	 better	 understand	 opioid	 use	problems.	
 	 Clinical	Notes	Models	(Third	Generation)	
 NLP	and	Text	Mining	These	 are	 risk	 assessment	 models	 that	 identify	 the	 presence	 of	 opioid	 use	problems	 through	 classifying	 patients’	 clinical	 notes	 using	 natural	 language	processing	and	text-mining	approaches.	 In	comparison	to	the	2	previous	methods,	
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NLP	 and	 text	 mining	 are	 more	 complex	 techniques	 that	 require	 intensive	computational	and	labor	skills.	Thus,	 in	our	review,	only	a	handful	of	studies	were	found	using	these	techniques	to	identify	opioid	use	problems.	In	this	thesis,	we	used	a	text-mining	approach	to	identify	opioid	use	problems	using	patient’s	clinical	notes.	Below	we	highlight	the	findings	of	our	research	within	the	context	of	similar	research	in	the	literature.	
Methods	and	Variables	Hylan	et	al.	(2015),	Carrell	et	al.	(2015),	and	the	subsequent	work	of	Palmer	et	al.	(2015)	are	a	 few	models	 found	that	use	NLP	to	 identify	opioid	use	problems	from	patients’	 clinical	 notes.	 Hylan	 et	 al.	 (2015),	 a	 two-year	 prospective	 study,	 used	 3	phases	of	NLP	to	identify	clinical	notes	with	indications	of	1-	opioid	overuse,	misuse,	abuse,	or	addiction	2-	opioid	dependence,	and	3-	“mentions”	of	ICD-9	codes	(12	ICD-	9	codes)	for	opioid	abuse	or	dependence	in	the	clinical	notes.	The	study	has	identified	158	(5.7%)	patients	with	opioid	use	problems,	while	ICD-9	for	the	same	cohort	has	identified	25	(0.9%).	Our	 study	 used	 dictionary-based	 NLP	 which	 was	 adopted	 from	 Carrell	 et	 al.	(2015)	for	2	reasons.	First,	as	the	opposite	of	Carrell	study’s,	Hylan	et	al.	(2015)	did	not	 specify	 the	 technical	 details	 of	 their	NLP	 process.	 Second,	 the	NLP	method	 of	Carrell	study’s	have	resulted	in	detecting	a	larger	percentage	of	opioid	use	problems.	Third,	Hylan	et	al.	(2015)	conducted	a	prospective	study	and	it	was	limited	to	primary	care	settings,	while	Carrell	et	al.	(2015)	conducted	a	retrospective	study	and	included	primary	care	and	emergency	department	notes.	To	note,	both	studies	drew	samples	from	the	Group	Health	population.	The	major	difference	was	in	the	study	period	(2	
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years	 vs.	 5	 years),	 study	 design	 (prospective	 vs.	 retrospective),	 and	 study	 sample	(primary	 care	 vs.	 primary	 care	 and	 emergency).	 In	 our	 study,	 the	 validated-text	mining	identified	127	(0.8%)	positive	OUP	cases	out	of	14,298	patients	while	ICD-9	has	 identified	 45	 (0.3%)	 positive	 OUP	 cases	 from	 the	 same	 population	 (total	combined	=	164	(1.1%)).	In	addition	to	the	NLP	classification,	both	studies	have	included	ancillary	analysis	of	 study	 cohort	 to	 estimate	 risk.	Hylan	 studied	prediction	 ability	 of	 7	 variables	 to	identify	a	positive	NLP	cohort.	These	variables	were	documented	for	the	2	years	prior	to	initiation	of	chronic	opioid	therapy.	These	variables	were:	Age	(15	to	44	or	45	to	64),	smoking	status,	and	2-year	prior	ICD	codes	for	the	following	diagnoses:	opioid	abuse/dependence,	 drug	 abuse/dependence	 (excluding	 opioids),	 alcohol	abuse/dependence,	mental	 health	 disorder,	 and	 hepatitis	 C.	 The	 study	 found	 that	using	multivariate	logistic	regression,	variables	indicating	age	18	to	44,	opioid	abuse	diagnosis,	positive	smoking	status,	and	mental	disorder	diagnoses	were	significant	predictors	 during	 the	 measured	 period.	 This	 study	 was	 limited	 to	 primary	 care	patients	of	an	integrated	group	practice,	salaried	physicians	working	in	Group	Health	Cooperative	(GHC)	clinics.	In	our	study,	validated-text	mining	identified	127	(0.8%)	positive	OUP	cases	out	of	14,298	patients,	while	ICD-9	identified	45	(0.3%)	positive	OUP	cases	from	the	same	population	 (total	 combined	 =	 164	 [1.1%]).	 We	 compared	 demographic	characteristics	and	variables	of	 interest	among	2	positive	groups	(text	mining	and	ICD)	using	Chisquare	and	independent	t-test.	We	have	also	compared	positive	OUP	using	text	mining	vs.	negative	OUP	for	the	same	variables	and	reported	multivariate	
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odds	ratio.	Our	variables	of	interest	included	non-opioid	abuse,	gender,	tobacco	Use,	self-Injury,	depression,	alcohol	abuse,	hepatitis	C,	age,	outpatient	visits,	emergency	department	 visits,	 hospitalizations,	 and	 cumulative	 hospitalization	 days.	 These	variables	were	chosen	subjectively	based	on	our	systematic	review	of	previous	work	and	 the	 feasibility	 of	 obtaining	 these	 variables	 from	 IUH	 and	 INPC	 databases.	Multivariate	analysis	logistic	regression	indicates	that	only	gender,	non-opioid	abuse,	self	injury,	outpatient	visits,	emergency	department	visits	and	inpatient	visits	were	significant	predictors	to	positive	text-mining	outcome	(Table	5.1).	Table	5.1	Multivariate	logistic	regression	of	text-mining	measure	of	opioid	use	problems	
Variables	 Odds	Ratio	 Lower*	 Upper*	Depression	 1.166	 0.612	 2.225	Age	Continuous	 0.915	 0.868	 0.965	Age	Group	 1.465	 0.854	 2.512	Sex	 1.62	 1.124	 2.335	Race	 0.928	 0.591	 1.456	Ethnicity	 1.202	 0.931	 1.553	Alcohol	Abuse	 1.869	 0.536	 6.519	Other	Medical	Abuse	 3.583	 1.409	 9.116	Tobacco	Use	 0.919	 0.473	 1.784	Self	Injury	 7.884	 1.35	 46.028	Hepatitis	C	 1.38	 0.348	 5.468	Outpatient	visits	 1.016	 1.003	 1.03	ED	visits	 1.093	 1.053	 1.135	Inpatient	Visits	 1.34	 1.138	 1.579	Hospital	Days	 0.983	 0.958	 1.009	*Odds	ratio	value	based	on	95%	confidence	interval		 Collectively,	 in	 addition	 to	 younger	 age,	 prior	 opioid	 diagnosis	 and	 mental	disorder,	our	study	findings	indicate	non-opioid	abuse,	self	injury,	outpatient	visits,	ED	visits	and	inpatient	visits	are	significant	variables	to	predict	opioid	use	problems	in	positive	NLP	and	text-mining	positive	cohort.	Our	reported	bi-variate	measure	of	association	 has	 also	 found	 alcohol	 abuse,	 hepatitis	 C,	 tobacco	 use,	 depression	 are	
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significant	associated	with	the	measured	outcomes.	One	common	limitation	of	both	studies	was	the	small	number	of	positive	outcome	(127	out	of	14,298	and	158	out	of	2,752),	which	affected	the	model	significance	to	predict	the	outcome.	This	could	be		Due	the	 limitations	 in	the	process	of	text	mining,	 itself,	and	inability	of	dictionary-based	 method	 to	 detect	 indication	 of	 opioid	 use	 problems	 in	 indirect	 or	 long	statements.	Such	statements	might	be	deemed	false	positive.	
Prevalence	of	Opioid	Use	Problems	We	measured	the	prevelence	of	opioid	use	problems	in	IUH	adult	patients	using	text	mining	and	ICD-9	codes.	In	our	study,	validated-text	mining	identified	127	(0.8%)	 positive	 OUP	 cases	 out	 of	 14,298	 patients,	 while	 ICD-9	 has	 Identified	 45	(0.3%)	positive	OUP	cases	from	the	same	population	(total	combined	=	164	[1.1%]).	Carrell	et	al	(2015)	Validated-NLP	method	has	identified	1,875	(8.5%)	patients	out	of	21,795	patients	eligible	for	the	study,	while	ICD-9	has	identified	2,240	(10.1%)	from	the	same	population.	the	disparities	between	the	2	results	was	vast	in	both	the	ICD	and	 text	 mining/NLP	 approaches	 despite	 both	 studies	 using	 the	 same	 eligibility	criteria	of	long-term	opioid	therapy	(or	chronic	opioid	therapy).	This	difference	could	be	attributed	to	one	or	more	of	the	following	factors:	First,	despite	both	studies	using	the	same	inclusion	criteria,	our	study	excluded	patients	with	schizophrenia	due	to	documented	higher	prevalence	of	OUP	among	this	population.	 However,	 this	 factor	 would	 have	 minimal	 effect,	 since	 only	 86	schizophrenic	patients	 (who	were	already	excluded	due	 to	 the	presence	of	 cancer	diagnosis)	were	additionally	excluded	from	the	study.		
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Second,	this	difference	could	be	attributed	to	the	time	and	study	period	of	the	2	 studies.	While	 the	 longest	 available	 follow-up	 period	 in	 our	 study	was	 2	 years,	Carrell’s	study	assessed	patients	over	a	5-year	period	from	2006-2012.	This	could	indicate	that	the	length	of	time	for	opioid	consumption	would	lead	to	an	increase	in	prevalence	of	opioid	problem.	One	critique	to	this	assumption	is	that	neither	study	measured	the	direct	effect	of	the	length	of	opioid	therapy	on	development	of	the	study	outcomes.	
	Figure	5.1	Opioid	overdose	death	rates	per	100,000	population	from	2006-2014.		Source:	Kaiser	Family	Foundation	[123]	Third,	 this	 could	be	 attributed	 to	 the	difference	between	opioid	problem	 rates	between	 the	 states	of	Washington	and	 Indiana	during	 the	 studied	period	 for	both	studies.	National	statistics	of	opioid	overdose	death	rates	(per	100,000)	shows	that	the	rate	of	opioid	overdose	deaths	in	Washington	state	ranged	from	10.2	to	9.2	during	Carrell’s	 study	period	 (2006-2012),	while	 the	 same	rate	 ranged	 from	5.7	 to	7.3	 in	Indiana	during	our	study	period	(2013-2014)	(Figure	5.1).	
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Finally,	 in	 the	 oppositition	 of	 Carrell’s	 study,	 our	 study	 did	 not	 have	 access	 to	behavioral\mental	health	reports	due	to	42	CFR	Part	2	-	confidentiality	of	substance	use	disorder	patient	records	regulations	[97].	We	believe	that	including	behavioral	health	reports	is	likely	to	identify	more	positive	cases	of	opioid	use	problems	in	our	study	population.	Collectively,	both	 studies	used	NLP	 to	 identify	opioid	use	problems	 in	primary	care	and	emergency	settings	and	compared	the	results	with	ICD-9	codes.	The	NLPtext	mining	 technique	 identified	 additional	 positive	 cases	 in	 both	 studies.	 Text-mining	approach	also	detected	15	patients	with	a	mention	of	ICD-9	code	of	opioid	abuse	and	dependence	 in	 patients’	 clinical	 notes	 but	 these	 codes	 were	 undocumented	 in	patients’	 record	 as	 structured	 data.	 This	 might	 indicate	 a	 significant	 lack	 of	documentation	 for	 opioid	 use	 problems	 and	 confirm	 previous	 studies’	 findings	regarding	 the	 underreporting	 of	 opioid	 problems	 using	 ICD	 codes.	 For	 future	research	pertaining	to	identifying	OUP,	we	recommend	using	alternate	methods	(in	addition	 to	 ICD	 codes),	 such	 as	 text	 mining	 and	 machine	 learning,	 and	 further	exploring	other	 commonly	documented	 structured	data,	 such	as	procedural	 codes	and	electronic	lab	results.	
 Machine	Learning	These	risk	assessment	techniques	utilize	a	set	of	statistical	techniques	to	identify	parts	of	speech,	entities,	sentiment,	and	other	aspects	of	text.	The	chosen	technique	can	be	expressed	in	models	that	can	be	applied	to	another	text	[124].	These	models	can	be	used	to	identify	a	particular	outcome	in	the	clinical	notes.	These	models	are	more	 flexible;	 to	 improve	 performance	 by	 training	 the	model	 on	 larger	 and	more	
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representative	 training	 sets	 and	 by	 choosing	 a	 suitable	 classifying	 algorithm.	 In	general,	the	learning	process	of	machine	learning	can	be	categorized	into	supervised	and	 unsupervised	 learning.	 Supervised	 learning	 means	 training	 documents	 are	tagged	with	a	specific	class	(e.g.,	positive,	negative),	while	unsupervised,	can	extract	meaning	without	a	specific	training	set.	A	common	example	of	unsupervised	training	is	data	clustering.	
Machine	Learning	in	Classification	of	Disease	In	our	review,	we	did	not	find	any	published	work	pertaining	to	machine-learning	models	 that	 classify	 clinical	 notes	 to	 identify	 opioid-addiction	 related	 behavior.	However,	we	found	several	studies	which	have	used	machine-learning	algorithms	to	classify	other	medical	events	such	as	chronic	disease	hospitalization,	or	particular	medical	condition	such	as	heart	failure	stage,	cancer	diagnosis	or	acute	pancreatitis	[125–128].	Despite	the	differences	in	the	outcome	of	interest,	the	general	theme	of	building	a	machine-learning	model	is	similar.	First,	identify	the	outcome	of	interest	and	source	of	clinical	notes	(e.g.	heart	failure	diagnosis	in	the	emergency	department	discharge	note).	 Second,	 identify	 training	 corpus	 (gold	 standard)	 using	 NLP/text-mining	approach	 (e.g.	 rule-based).	 Third,	 build	machine-learning	model	 and	 evaluate	 the	performance	(by	reporting	F-measure,	recall	and	precision).	
Machine-Learning	to	Identify	Opioid	Use	Problems	In	 this	 thesis,	 similar	 steps	were	 adopted	 to	build	machine-learning	predictive	models	 to	 identify	 opioid	 use	 problems	 among	 long-term	 therapy	 patients	 at	 IUH	using	clinical	notes.	We	built	on	our	previous	effort	in	text	mining	to	investigate	the	
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application	of	machine-learning	techniques	to	classify	opioid	use	problems	utilizing	patients	clinical	notes.	We	manually	reviewed	a	list	of	positive	and	negative	clinical	notes	 that	 resulted	 from	 the	 text-mining	 study,	 which	we	 then	 used	 to	 build	 our	machine-learning	 model.	 We	 tested	 5	 different	 algorithms	 to	 classify	 opioid	 use	problems	at	 the	document	 level.	 Simple	Logistic	 regression	showed	overall	higher	accuracy	 performance	 measures	 in	 classifying	 positive	 opioid	 use	 problems	 on	balanced	dataset.	Our	final	model	was	tested	on	unseen	data	and	reported	a	recall	of	88%	and	precision	of	66%	(F-measure	=	76%)	when	identifying	positive	cases.	Despite	 our	 findings	 the	 results	 of	 identifying	 opioid	 use	 problems	 are	encouraging,	 our	 outcome	 of	 interest	 (OUP),	 comprised	 of	 multiple	 behavioral	concepts,	such	as	dependence,	abuse,	addiction,	and	overdose.	While	distinguishing	specific	behavioral	concepts	was	not	automated	 in	 this	 research,	 future	work	may	investigate	the	use	of	text	mining,	natural	language	processing,	and	machine	learning	to	 better	 target	 specific	 behaviors	 before	 considering	 using	 these	 for	 surveillance	purposes	or	incorporating	them	into	a	clinical	decision	system	for	primary	care	and	emergency	encounters.	
 Limitations	In	this	thesis,	we	used	a	text-mining	approach	to	analyze	patients	clinical	notes	to	identify	OUP.	Due	 to	 labor	 constraints,	our	analysis	was	 limited	 to	5	 report	 types,	despite	 our	 effort	 to	 rely	 on	 expert	 opinions	 to	meaningfully	 limit	 the	 number	 of	report	types.	This	approach	might	have	systematically	overlooked	a	certain	group	of	positive	 OUP	 patients.	 Since	 our	 gold	 standard	 data	 was	made	 through	manually	reviewing	 a	 text-mining	 algorithm	 to	 identify	 opioid	 use	 problems,	 any	 positive-
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report	 subclass	 that	 was	 not	 captured	 by	 the	 text-mining	 algorithm	 may	 not	 be	represented	in	our	model.	To	account	for	this	limitation,	we	have	intentionally	added	all	 falsepositive	 reports	 as	 part	 of	 our	 training	model	 labeled	 as	negative	 reports.	Further,	 a	 random	sample	 of	 500	negative	 reports	 (by	 the	 text-mining	 algorithm)	were	manually	reviewed	and	false-negative	reports	were	added	to	into	the	training	set	as	positive	cases.	
 Conclusion	This	study’s	main	contribution	was	to	demonstrate	 the	validity	of	using	a	 text-mining	approach	and	machine-learning	techniques	to	identify	opioid	use	problems	from	patients’	clinical	notes	in	multi-site	medical	care	facilities.	Our	research	has	also	highlighted	the	main	demographic	characteristics,	care	utilization,	and	co-morbidity	similarities	 and	 differences	 among	 opioid	 use	 problems	 identified	 by	 text	mining	versus	the	opioid	use	problems	identified	by	ICD	codes.	Additionally,	this	research	has	compared	multiple	machine-learning	algorithms’	performance	to	identify	opioid	use	 problems	 from	patients’	 clinical	 notes	 and	 has	 reported	 their	 performance	 to	inform	future	research.	
 Future	Direction	and	Recommendations	Based	on	the	results	from	this	thesis,	future	research	may	focus	on:	1. Further	analyzing	machine-learning	capability	to	identify	opioid	use	problems	from	 clinical	 notes.	We	 recommend	 to	 build	machine-learning	model	 that	 is	based	on	larger	validated	training	corpus	which	comprised	of	multiple	years	of	patient’	clinical	notes.	
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2. Comparing	text-mining	approach	against	ICD-10	to	understand	first,	whether	ICD-10	documentation	to	OUP	has	changed	from	ICD-9	and	second,	to	further	study	the	pattern,	if	any,	for	the	OUP	cases	missed	by	ICD	codes.	3. Exploring	the	idea	of	adopting	a	hybrid	approach	that	combines	ICD	codes	in	addition	 to	 patients	 clinical	 notes	 (text	 mining	 or	 machine	 learning).	Incorporating	 such	 approach	 may	 synergize	 the	 ability	 of	 future	 models	 to	identify	the	opioid	issue.	4. Focusing	on	measuring	the	relationship	between	opioid	use	problems	and	the	length	of	opioid	treatment	in	long-term	opioid	therapy	patients.	5. Investigating	the	use	of	text	mining,	natural	language	processing	and	machine	learning	 to	 better	 target	 specific	 opioid	 use	 problems	 behaviors	 (such	 as	overdose	 vs.	 abuse)	 before	 incorporating	 these	 techniques	 into	 surveillance	purposes	 or	 adopting	 it	 into	 a	 clinical	 decision	 system	 for	 primary	 care	 and	emergency	encounters.
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6. APPENDICES	
 CHAPTER	3	SUPPLEMENTS	
	Appendix	A.1	Venn	diagram	of	the	overlap	between	the	two	positive	cohorts	of	opioid	Use	problem	in	the	study		 	
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Appendix	 A.2	 Terms	 used	 by	 nDepth™	 algorithm	 to	 identify	 (flag)	 OUP	 positive	reports	
Opioid	terms	 Problem	use	terms	codeine	 analgesic	 addict	 abusing	 aberrancy	codeine	 narcotic	 addicted	 misusing	 aberrant	codeine	 opiate	 addiction	 overusing	 daiversion	fentanyl	 opioid	 	 over	using	 divert	hydrocodone	 	 	 abuse	 	methadone	 	 	 abuser	 	morphine	 	 	 misuse	 	oxy	 	 	 misuser	 	oxy-ir	 	 	 overuse	 	oxycod	 	 	 overuser	 	oxycodone	 	 	 over	use	 	oxyContin	percocet	polypharmacy	vico	Vicodin	 	 over	user		Appendix	A.3	Highlighted	phrases	used	in	the	semi-assisted	manually	review	process	
Semi	assisted	manual	review	highlighted	words	abus*	 opioid	use	disorder	 diversion/divert	misus*	 dependent	 high	overus*	 dependency	 euphoria	over	us*	 heroin	 abnormal	urine	drug	screen	Addict*	 Crav*	 dirty	urine	inconsistent	urine	 Lost	prescriptions	 alcohol	abus*	unauthorized	dose	increase	 Less	suggestive	words	 early	refills	taking	more	than	prescribed	 marijuana	 immediate	taper	Narcan	 narcotic	 naloxone				
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Appendix	A.4	ICD-9	codes	used	to	define	OUP	
Class	Codes	
Diagnosis	Category	 ICD-9-CM	Codes	Opioid	Abuse	and	dependence	 1. 304.00	(opioid	dependence	unspecified)	2. 304.01	(opioid	dependence	continuous)	3. 305.50	(opioid	abuse	unspecified)	4. 305.51	(opioid	abuse	continuous)	5. 304.71	(opioid/other	dependence	continuous)	6. 304.02	(opioid	dependence	episodic)	7. 304.70	(opioid/other	dependence	unspecified)	8. 305.52	(opioid	abuse	episodic)	9. 304.72	(opioid/other	dependence	episodic)	Poisoning	 10. Non-specific	code	965	Poisoning	by	analgesics	antipyretics	and	antirheumatics	11. Non-specific	code	965.0	Poisoning	by	opiates	and	related	narcotics	12. Specific	code	965.00	Poisoning	by	opium	(alkaloids),	unspecified	13. Specific	code	965.01	Poisoning	by	heroin	14. Specific	code	965.02	Poisoning	by	methadone	15. Specific	code	965.09	Poisoning	by	other	opiates	and	related	narcotics	16. E850.0	Accidental	poisoning	by	heroin	17. E850.1	Accidental	poisoning	by	methadone	18. E850.2	Accidental	poisoning	by	other	opiates	and	related	narcotics			Appendix	A.5	Frequency	distribution	of	positive	ICD-9	codes	for	OUP	
Frequency	distribution	of	positive	ICD-9	codes	for	OUP	
ICD-9	Codes	 Description	 N	(%)	304	 opioid	dependence	unspecified	 24	(49%)	305.5	 opioid	abuse	unspecified	 9	(18%)	304.01	 opioid	dependence	continuous	 5	(10%)	965	 Non-specific	code	965.0	Poisoning	by	opiates	and	related	narcotics	 3	(6%)	965.01	 Specific	code	965.01	Poisoning	by	heroin	 3	(6%)	E850.2	 E850.2	Accidental	poisoning	by	other	opiates	and	related	narcotics	 2	(4%)	E850.0	 E850.0	Accidental	poisoning	by	heroin	 1	(2%)	965.09	 Specific	code	965.09	Poisoning	by	other	opiates	and	related	narcotics	 1	(2%)	304.71	 opioid/other	dependence	continuous	 1	(2%)	
Grand	Total	 49	(100)	*	*4	out	of	45	patients	had	two	positive	ICD-9	codes	for	OUP		
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 CHAPTER	4	SUPPLEMENTS	Appendix	B.1	J48	model	performance	on	80%	of	the	gold	standard	data	
Class	 TP	
Rate	 FP	Rate	 s	Precision	 Recall	 F-	Measure	 ROC	Area	Positive	 0.691	 0.092	 0.707	 0.691	 0.699	 0.808	Negative	 0.908	 0.309	 0.902	 0.908	 0.905	 	Weighted	Avg.	 0.855	 0.256	 0.854	 0.855	 0.855	 		Appendix	B.2	Naive	Bayes	model	performance	on	80%	of	the	gold	standard	data	
Class	 TP	
Rate	 FP	Rate	 Precision	 Recall	 F-	Measure	 ROC	Area	Positive	 0.625	 0.146	 0.578	 0.625	 0.601	 0.851	Negative	 0.854	 0.375	 0.877	 0.854	 0.865	 0.776	Weighted	Avg.	 0.798	 0.319	 0.804	 0.798	 0.801	 0.794		Appendix	B.3	Random	forest	model	performance	on	80%	of	the	gold	standard	data	
Class	 TP	
Rate	 FP	Rate	 Precision	 Recall	 F-	Measure	 ROC	Area	Positive	 0.485	 0.160	 0.493	 0.485	 0.489	 0.662	Negative	 0.840	 0.515	 0.836	 0.840	 0.838	 	Weighted	Avg.	 0.754	 0.429	 0.752	 0.754	 0.753	 		Appendix	B.4	SMO	model	performance	on	80%	of	the	gold	standard	data	
Class	 TP	
Rate	 FP	Rate	 Precision	 Recall	 F-	Measure	 ROC	Area	Positive	 0.721	 0.083	 0.737	 0.721	 0.729	 0.819	Negative	 0.917	 0.279	 0.911	 0.917	 0.914	 	Weighted	Avg.	 0.870	 0.232	 0.869	 0.870	 0.869	 		Appendix	B.5	Simple	logistic	model	performance	on	80%	of	the	gold	standard	data	
Class	 TP	
Rate	 FP	Rate	 Precision	 Recall	 F-	Measure	 ROC	Area	Positive	 0.728	 0.052	 0.818	 0.728	 0.770	 0.940	Negative	 0.948	 0.272	 0.916	 0.948	 0.932	 	Weighted	Avg.	 0.895	 0.219	 0.892	 0.895	 0.892	 	
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Appendix	B.6	A	list	of	document,	sentence	and	phrase	performance	measure	to	classify	positive	class		 Accuracy	Measures	
Level	 Algorithm	 Precision	 Recall	 F-Measure	
Document		 SimpleLogistic	 0.918	 0.904	 0.911		 J48	 0.847	 0.853	 0.85		 RandomForest	 0.756	 0.934	 0.836		 BinarySMO	 0.797	 0.838	 0.817		 NaiveBase	 0.821	 0.64	 0.719	
Sentence	 RandomForest	 0.867	 1	 0.929		 BinarySMO	 0.867	 1	 0.929		 SimpleLogistic	 0.856	 1	 0.922		 NaiveBase	 0.856	 1	 0.922	
Phrase	 RandomForest	 0.864	 1	 0.927		 BinarySMO	 0.864	 1	 0.927		 SimpleLogistic	 0.859	 1	 0.924		 NaiveBase	 0.859	 1	 0.924		 	
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 WEKA	DEMONSTRATION	
	Appendix	C.1	Click	Explorer	to	open	WEKA		
	Appendix	C.2	Click	Open	file	
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	Appendix	C.3	Choose	ARFF	training	data	file	from	computer	
	Appendix	C.4	Double-	check	data	before	proceeding	
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	Appendix	C.5	Click	Choose	to	open	classifier	options		
	Appendix	C.6	Choose	filtered	classifier		
	Appendix	C.7	Right	click	on	classifier	name	and	click	show	properties	
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	Appendix	C.8	Click	Choose	to	open	classifiers	list	
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	Appendix	C.9	Choose	a	classifier	[e.g.,	simple	logistic]	
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	Appendix	C.10	Click	Choose	to	open	filter	options	
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	Appendix	C.11	Choose	StringToWordVector	
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	Appendix	C.12	Right	click	on	filter	name	and	click	show	properties	
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	Appendix	C.13	Suggested	filter	settings	for	text	classifications	
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	Appendix	C.14	Suggested	filter	settings	for	text	classifications	continues	
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	Appendix	C.15	From	main	classify	tab,	click	More	options	
	92	
	Appendix	C.16	Click	Choose	to	open	output	predictions	
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	Appendix	C.17	Choose	cross-validation	and	classifying	attribute		
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	Appendix	C.18	Prediction	results	are	shown	in	the	buffer	
	Appendix	C.19	Accuracy	measures	and	model	performance	results	are	shown	at	the	end	of	the	buffer	results		
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	Appendix	C.20	Right	click	on	classifier	name,	then	click	show	properties	
	Appendix	C.21	Click	Choose	to	open	classifier	options	
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	Appendix	C.22	Choose	Cost	Sensitive	Classifier	
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	Appendix	C.23	Right	click	to	show	properties	
	Appendix	C.24	Click	choose	to	open	classifier	options	and	choose	a	classifier	
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	Appendix	C.25	Right	click	on	cost	matrix	to	show	properties	
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	Appendix	C.26	Change	classes	number	according	to	the	study	classes,	then	click	resize	
	100	
	Appendix	C.27	Cost	Matrix	now	reflects	study	classes	count		
	Appendix	C.28	Adjust	penalty	as	needed.	Train	the	model		 	
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 JAVA	CODES	TO	EXTRACT	TEXT	Appendix	D.1	Codes	to	extract	text	from	PDF	inspired	by	Dara	Yuk	original	code	[129]	package	abdullah	;	import	 java	 .	 io	 .	 File	 ;	 import	 java	 .	 io	 .	 FileInputStream	 ;	 import	 java	 .	 io	 .	FileOutputStream	;	import	java	.	io	.	FileReader	;	import	java	.	io	.	FileWriter	;	import	java	.	io	.	BufferedWriter	;	import	java	.	io	.	IOException	;	import	com.	itextpdf	.	text	.	Document	;	import	com.	itextpdf	.	text	.	pdf	.	PdfReader	;	import	com.	itextpdf	.	text	.	pdf	.	parser	.	PdfTextExtractor	;	import	java	.	awt	.	Desktop	;	import	javax	.	swing	.	filechooser	.	FileNameExtensionFilter	;	import	javax	.	swing	.	JFileChooser	;	/∗∗	∗	∗	@author	∗/	public	 class	PDFToTextConverter	{	public	static	void	main(	String	[	]	args	){	selectPDFFiles	();	}	//allow	 pdf	 f	 i	 l	 e	 s	 selection	 for	 converting	 public	 static	 void	selectPDFFiles	(){	JFileChooser	chooser	=	new	JFileChooser	();	FileNameExtensionFilter	f	i	l	t	e	 r	 =	 new	 FileNameExtensionFilter	 (”PDF”	 ,”	 pdf	 ”);	 chooser	 .	setFileFilter	(	f	i	l	t	e	r	);	chooser	.	setMultiSelectionEnabled	(	true	);	int	returnVal	=	chooser	.	showOpenDialog(	null	);	String	path=	F	i	l	e	P	a	t	h	;	i	f	(	returnVal	==	JFileChooser	.APPROVE	OPTION)	{	File	[	]	Files=chooser	.	getSelectedFiles	();	System	.	out	.	println	(”	 Please	 wait	 .	 .	 .	 ”	 )	 ;	 for	 (	 int	 i	 =0;i<Files	 .	 length	 ;	 i++){	convertPDFToText(	Files	[	i	]	.	toString	()	,	path	+	Files	[	i	]	.	getName	().	substring	(0	,	Files	[	i	]	.	getName	().	length	()−4)+”.	txt	”);	}	System	.	out	.	println	(”	Conversion	complete	”);	}	}	public	 static	 void	convertPDFToText(	String	 src	,	String	 desc	){	try{		 //	create	 f	i	l	e	 writer	FileWriter	fw=new	FileWriter	(	desc	);		 //	create	 buffered	 writer	BufferedWriter	bw=new	BufferedWriter	(fw	);		 //	create	 pdf	reader	PdfReader	pr=new	PdfReader(	src	);	//get	the	number	of	pages	in	the	document	int	pNum=pr	.	getNumberOfPages	();	for	(	int	page=1;page<=pNum;	page++){	String	text=PdfTextExtractor	.	getTextFromPage(pr	,	page	);	bw.	write	(	text	);	bw.	newLine	();	
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}	bw.	flush	();	bw.	close	();	}catch	(	Exception	e){e	.	printStackTrace	();}	}	}		 	
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Appendix	D.2	Codes	to	extract	text	from	CSV	package	abdullah	;	import	java	.	io	.	BufferedReader	;	import	java	.	io	.	BufferedWriter	;	import	java	.	io	.	File	;	import	java	.	io	.	FileNotFoundException	;	import	java	.	io	.	FileReader	;	import	java	.	io	.	FileWriter	;	import	java	.	io	.	IOException	;	import	java	.	util	.	StringTokenizer	;	/∗∗	∗	∗	@author	∗/	public	 class	 Abdullah	{	/∗∗		 ∗	@param	args	the	command	line	 arguments	∗/	 public	 static	 void	 main(	 String	 [	 ]	 args	 )	 throws	FileNotFoundException	,	IOException	{	File	 =	 new	 File	 (	 F	 i	 l	 e	 P	 a	 t	 h	 );	 BufferedReader	 br	 =	 new	BufferedReader	(new	FileReader	(	f	i	l	e	));		 String	 line	;		 StringTokenizer	 st	;	int	counter	=	0;	while	((	line	=	br	.	readLine	())	!=	null	)	{	st	=	new	StringTokenizer	(	line	,	”\t	”);	i	f	(	st	.	countTokens	()	>=	3)	{	st	.	nextToken	();	String	name	=	st	.	nextToken	()	+	”.	txt	”;	BufferedWriter	out	=	new	BufferedWriter	(new	FileWriter	(”	FilePath”	+	name	));	st	.	nextToken	();	i	f	 (	st	.	hasMoreTokens	())	{	out	.	write	(	st	.	nextToken	());	}	else	{	 out	.	write	(””);	}	out	.	close	();	counter++;	}	 //	(	st	.	countTokens()==4)	else	{	System	.	err	.	println	(”	line	\t”	+	counter	);	counter++;	}	}	//	while	}	}		 	
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